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Abstract· of a thesis subm itted in partial 
fulfilment of the requirements for the 
degree of Master of Science 
Quantification of the calpain proteolytic system, and 
the effects of growth hormone enhancer and 
selection for glucose tolerance on the 
calpain proteolytic system and tenderness in lambs. 
by 
Matthew Peter Kent 
The calpain proteolytic system has been implicated in determining the tenderness of post-
mortem muscle. An appreciation of factors that impact upon this system may allow 
commercial meat producers and processors to generate meat of greater tenderness. lbis 
thesis examines the effect of glucose tolerance and growth hormone enhancer on the activity 
of enzymes belonging to the cal pain system, with a view to developing a better 
understanding of the system. 
A variety of ion exchange and hydrophobic chromatography methods used to extract calpains 
were compared. DEAE based methods of extraction were superior to phenyl sepharose with 
respect to accuracy and reproducibility of calpain separation. A protocol was developed and 
used in subsequent experiments. 
Previously sheep had been bred selectively based upon their rates of glucose clearance. The 
two lines produced, displayed fast and slow clearance and also presented differing body 
compositions. Fast sheep generally had lower % protein but higher % fat compared to slow 
(p<O.05). Fast sheep also had significantly greater (p<O.05) activity of calpain I and II 
extracted from post-mortem skeletal muscle, and lower calpastatin. This may indicate that 
the lower % protein was attributable to augmented proteolytic enzyme levels. Enzyme levels 
were not correlated with differences in tenderness or pH of meat from these animals. 
Immunogenic peptide fragments of growth hormone can associate with antibodies and 
generate an amplified OH response. Experiments were performed to confirm this by 
injecting lambs with a OH peptide. No effect on growth rate was observed, although an 
~ -
immune response did occur. TIlls treatment had no effect on body composition or calpain 
activity, and no differences in tenderness were observed. 
This work succeeded in developing a reliable protocol for the extraction and quantification of 
the calpain system. Heightened protease levels were correlated with lower protein content in 
sheep selected for fast clearance of glucose. 111is may indicate a function for the calpains in 
in vivo nutrient partitioning. The OH enhancing peptide used in this work failed to produce 
a change in the hormonal status of the animals. and had no effect on meat quality. 
Keywords: Calpain, calpastatin, sheep, chromatography, glucose 
tolerance, growth hormone enhancer, meat tenderness. 
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Chapter 1 . 
Review of Literature 
1.1 Introduction 
f. / 
Meat tenderness is one of the most important characteristics of meat quality (Lawrie 1991), and 
inconsistency in meat tenderness is a major concern to consumers and producers. Muscle 
connective tissues (collagen, elastin, reticulin and mucopolysaccharides) are responsible for the 
'background toughness' of meat. While the contractile apparatus (actin, myosin. and tropomyusin) 
is accountable for the more variable 'myofibrillar toughness'. The development of tender meat is 
incompletely understood, particularly with respect to the biochemical changes that take place. This 
chapter presents current knowledge of meat tenderisation with a particular focus on proteolysis. 
Within the conversion of muscle to meat, Geesink (1993) has distinguished two phases shown in 
Figure 1. t: 
Toughness 
I 
~ 
l , 
Rlgormonis 
!. . . . . .. ....... . 
Background toughness 
o 2 3 4 5 6 7 8 9 10 
Days post·mortem 
Figure 1.1 A schematic diagram of the effect of ageing on meat tenderness. 
[be first phase is characterised by the muscle becoming inextensible: this stiffening is referred to as 
igor mortis or rigor. and is positively correlated with the disappearance of A TP (Lawrie 1991), In 
he absence of ATP, actin and myosin combine to form rigid chains of actomyosin. this process is 
r;lji>::;~ 
I 
- _. . ... -.----~ ..... 
..... .. _---_. 
;low at fIrst (delay period), but later becomes more rapid (fast phase). The time required till onset 
)f the fast phase depends upon post-mortem glycolysis, which can resynthesise A TP. Electrical 
;timulation of whole carcasses is often used to accelerate glycolysis and the onset of rigor mortis. 
Because blood flow to the muscle has ceased, glycolysis becomes an anaerobic process and 
)roduces lactic acid. As a result, tissue pH declines from about 7.2 to 5.5. 
rhe second phase in conve($ion of meat to muscle is the gradual improvement in tenderness during 
itorage sometimes referred.to as conditioning (Etherington 1991). Storing post-mortem muscle 
ageing) for up to 3 weeks in a chiller produces noticeable improvements in tenderness and is 
'outinely implemented. However, the method has drawbacks such as the long processing time, 
itorage cost, and the potential for spoilage (DransfIeld 1994). 
Jltimate tenderness of meat depends on a number of biological and environmental factors such as 
1ge, sex, muscle type, stress, protease activity, growth promoters and electrical stimulation. 
:onsequently, the optimum ageing period differs literally from animal to animal and makes 
,rediction of tenderness at anyone time difficult. The process of meat tenderisation has been 
tudied intensively over the last 20 years, and an improved although still incomplete understanding 
If the mechanism of tenderisation has developed . 
. 2 Muscle conditioning 
1.2.1 Skeletal muscle proteins 
:keletal muscles are composed of approximately 75% water, 20% protein and variable amounts of 
pid, carbohydrate and other organic compounds (Geesink 1993; Lawrie 1991). The essential 
tructural unit of all muscles is the fibre. These are long, narrow, multineucleated cells which 
xtend thro.~gh !he muscle. They may attain a length of up to 34cm and have diameters of 10-
001lffi. Within a muscle, fIbre diameters vary and usually smaller fIbres are peripheral while large 
re centralised. Each contractile fibre is surrounded by the sarcolemma. and is compos~d of many 
lyofibrils which contain contractile filaments. Each myofIbril is surrounded by the sarcoplasmic 
:ticulum which stores Ca2+. 
2 
Muscle fiber 
[ I 
Sarcomere 
Figure 1.2 A schematic overview of muscle fibre structure (from Hill and Wyse 1989). 
he smallest contractile unit is the sarcomere which consists of thick myosin filaments and thin 
:tin filaments. Approximately 95% of total muscle protein is found in the myofibril, and is 
lassified as being either sarcoplasmic or myofibrillar. The latter classification is further subdivided 
Ito contractile. regulatory or cytoskeletal proteins (Geesink 1993). Myosin and actin are the main 
)ntractile proteins, while the troponins (C. I and T) and tropomyosin are the regulatory proteins 
'hich control interaction between actin and myosin. Cytoskeletal proteins form a structural 
~twork within the muscle cell and these include titin and desmin. 
3 
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1.2.2 Post-mortem changes in muscle 
Post-rigor tenderisation during conditioning is not due to breakdown of the actomyosin complex 
rather, current data suggests that deterioration of key myofibrillar proteins is the principle 
mechanism behind meat tenderisation (Koohmaraie 1994). Specifically, this involves weakening 
and degradation of Z-discs.at the site of thin (actin) filament attachment (Etherington 1991). 
Degradation of desrnin anij titin is seen simultaneously with the increased fragility of muscle fibres 
during post-mortem storage. A summary of some post-mortem changes in muscles includes: 
• Z-disc weakening ,and degradation, leads to myofibril fragmentation (Suzuki et al., 
1982); 
• Desrnin degradation, leads to myofibril fragmentation (Wheeler et al., 1994); 
• Titin degradation, leads to loss of muscle elasticity and connections between myofibrils 
(Koohmaraie 1994); 
• Nebulin degradation, does not effect tenderness; 
• Degradation of troponin-T and appearance of polypeptide fragments. Decline in 
troponin-T does not effect tenderness, however its fragmentation is a good post-mortem 
proteolysis indicator (Wheeler et al., 1994). 
2learly all these changes require some proteolysis, and today there is little doubt that proteases are 
responsible for these changes and account for most post-mortem tenderisation (Etherington 1991; 
3eesink 1993; Uytterhaegen et at., 1994; Dransfield et at., 1992a; Dransfield 1994; Koohmaraie 
1994; Whipple et at., 1991). 
1.2.3 Proteases involved in post-mortem tenderisation 
K.oohmaraie (1994) states that for a protease to have a role in post-mortem tenderisation, it must: 
• 
• 
be located in animal muscle cells; 
have access to substrate (ie., myofibrils); 
It have the ability to degrade the proteins that are degraded during the tenderisation 
process. 
wee candidates proteolytic mechanisms fulfil these criteria. They are the lysosomal proteases 
cathepsins), the multicatalytic protease complex and the cal pains. 
4 
1.2.3.1 The Cathepsi ns 
Gathepsins are distinct from other intracellular proteases in that they designed to function in an 
aCidic milieu, and are localised to the lysosomes (Matthews et at., 1990). It is thought that 
cathepsins are not likely to playa role in tenderisation for several reasons. The primary substrates 
of the cathepsins are the contractile proteins (actin and myosin) and breakdown of these proteins is 
not observed under norm~l post-mortem storage conditions (Lawrie 1991). Furthermore, cathepsins 
are sequestered within lysosomes and there is no evidence to suggest that these organelles are 
ruptured during post-mortem changes (Koohmaraie 1994; Whipple et at., 1991), even after 
electrical stimulation and storage for 28 days at 4°C (Dransfield 1992a). 
1.2.3.2 Multicatalytic protease complex 
The multicatalytic protease complex (MCP) is a high molecular weight enzyme (Mr 650-700kOa) 
composed of multiple units with molecular mass of 22-34kDa (Koohmaraie 1992b; Rivett 1993; 
Arbona e~ at., 1993). While MCP is believed to playa major role in extralysosomal proteolysis 
(Figueiredo-Pereira et at., 1994), its role in muscle protein degradation is uncertain. However, 
electron microscopic studies would suggest the MCP has no effect on myofibrils (Koohmaraie 
1992b), and SDS-PAGE data suggests it only degrades troponin-C and myosin light chain-l and -2. 
Thus it is concluded by Koohmaraie (1994) that MCP has little effect on post-mortem tenderisation. 
1.2.3.3 The Calpains 
There is substantial experimental evidence to indicate a role for the calpains and their inhibitor 
calpastatin in tenderisation Dransfield 1994; Koohmaraie 1988/1994). 
1.3 The Calpain proteolytic system 
The calpain proteolytic system (calpain system) is a soluble non-lysosomal protease system 
responsible for a portion of intracellular protein degradation (for reviews see Rivett 1990; Murachi 
1989; Melloni et at., 1991; Koohmaraie 1988). Certain features of this system indicate that it may 
have a role in intracellular signal transduction. These include the nature of some of its substrates, 
and the modulation of its activity by calcium. Other possible functions of this system are platelet 
activation and coagulation (Basse et al., 1994), apoptosis (Squier et al., 1994), development of 
Alzheimer's disease (Saito et al., 1993), development of cataracts (David 1993; Azuma et al., 1992) 
and myoblast fusion during muscle growth (Ebisui et at., 1994). 
5 
1.3.1 Components of the Cal pain system 
Two proteolytic components of the calpain system have been identified (Mellgren et at .. 1982). 
They are alternatively known as calcium activated neutral protease (CANP) I and II, Ca2+-activated 
protease (CAP, Suzuki et at., 1982), Il-calpain and m-calpain (Murachi 1989), or calpain I and 
calpain II (EC 3.4.22.17) .. TIlis classification is based on contrasts in their sensitivity to calcium 
(Suzuki et at., 1987). Ttlus cal pain I requires a concentration of Ca2+ between 2 and 101lM for 
maximum in vitro activity, whereas calpain II requires a concentration of Ca2+ close to ImM 
(Salamino et at., 1993). A third element of this system is the specific endogenous inhibitor protein 
which Murachi (1989)named calpastatin. 
The calpains and calpastatin are widely distributed in the animal kingdom, and in addition to 
mammals and birds they have been identified in fish. crustaceans, and insects (Murachi 1989), 
plants (Bulaj et at., 1990) and fungi (Huber et ai., 1994). The palpain isoforms have been 
identified in all animal cells examined. with the exception oflirculating blood cells (Melloni et ai., 
1991). Calpastatin is present in all cells containing theMo proteases, however, the ratio of these 
three components is variable between tissues and species (Quall et ai .. 1990). 
Both calpains (Mr llOkDa) are heterodimeric proteins incorporating a large 80kDa subunit and a 
smaller 30kDa subunit. Four domains have been identified in the large SUbunit, and two in the 
small (see Figure 1.3) 
urve SubunH (SOkD.) 
prot .... dom.ln 
Small Subunit 
III 
calmodulin-like 
ea"-blndlng domeln 
700 
(30kDa) . 
Gly-rich calmodulin-like 
hydrophobic domain ea"-blndIng domain 
Figure 1.3 Domain structure of calpains I and II comprising a large (80kDa) and a small 
(30kDa) subunit (Adapted from Suzuki et ai., 1992). 
6 
Murachi (1989) reports that the 80kDa subunits of calpains I and II are genetically distinct proteins, 
while the 30kDa subunits are identical. The N-terminal domain I serves two related functions. 
Firstly, its cleavage possibly promotes conversion of the inactive proenzyme into active enzyme, 
and secondly its removal liberates the enzyme from its membrane association. The amino acid 
sequence of domain II resembles other cysteine proteases and is therefore thought to be the 
enzymes active site. Mocijfication of domain II's structure does not prevent binding of cal pain to 
calpastatin suggesting thaJ interaction does not depend exclusively upon the active site structure 
(Crawford et at., 1993). ,Consequently, domain III is thought to be the calpastatin binding region, 
and facilitates regulation of domain II. Domains IV of the large subunit and IV' of the small, 
embrace a calmodulin-like amino acid sequence with 4 EF hand structures (Suzuki et at., 1992). 
The EF hand motif is a reoccuring structure formed by a helix-loop-helix unit which represents the 
Ca2+ binding site in Ca2+ binding proteins (Stryer 1988). This suggests a Ca2+ binding role for this 
region. The small subunit has a second domain (domain V) which probablyh~~ regulatory 
function since its removal increases the sensitivity of the enzyme to Ca2+ (Melloni et at., 1991). 
Interestingly, a minireview recently published by Sorimachi et at., (1994) announced the discovery 
of severa! new calpain species. It has been revealed that the large subunit comprises a family of at 
least six members, which can be categorized as ubiquitous (I~ and 11- types) or tissue specific 
(p94/nCL-1 specific for skeletal muscle, NCL-2/-2' specific for stomach) calpains. 
Pontremoli et at., (1991) has identified two forms of calpastatin differing in their specificity for 
calpains 1 and II. Calpastatin 1 appears more effective against calpain I, while calpastatin II is 
effective against calpain II. The two forms can be interconverted by a phosphorylation-
dephosphorylation reaction, and in vivo this reaction is performed by a CAMP-dependant protein 
kinase A (Salarnino et at., 1994). The rudimentary calpastatin (Mr 105-11OkDA) is monomeric and 
consists of an N-terminal domain (domain L) followed by four homologous domains (domains 1-4). 
Each domain embraces approximately 140 amino acid residues. By expressing domains 1-4 
individually in E.coli plasmids, Murachi (1989) illustrated calpain specific inhibitory activity, in 
contrast to domain L which displayed none. This suggests it is these homologous regions that 
confer inhibitory potential to the protein. Each domain (1-4) can be divided into 4 subdomains 
(eg .. lA, 1B, lC and 1D) composed of 27-33 residues. An experiment performed by Maki et at., 
(1989) established that a chemically synthesised 27 residue oligopeptide of domain 1 B possessed 
potent inhibitory potential. This endorses the report that calpastatin can be fragmented by calpain 
into peptides which display almost complete inhibitory potential (Melloni et at., 1991). In theory, 
therefore, one calpastatin should be capable of inhibiting four calpain molecules. However, this 
stoichiometric relationship is not typical in either recreated systems or in intact cells. Ca2+ is 
required for the inhibition of calpain by calpastatin (Crawford et at .. 1993). and the mode of 
7 
inhibition is competitive and fully reversible, leading to a fully active enzymes upon dissociation .. 
1.3.2 Activation of the Cal pain protease system_ 
There is general agreement that the mechanism for activation of cal pain protease requires the 
::onversion of inactive proel)Zyme to active enzyme via autoproteolysis (McClelland et ai., 1989; 
Melloni et ai., 1984). Spe~ifically, this involves the cleavage of domain I (Suzuki et al., 1992), 
md possibly domain V (Melloni et aI., 1991) from both, or either, subunits. This conversion is 
jependant upon relatively high Ca2+ concentrations (ie., 5mM for calpain II and ImM for calpain I 
:Nishimura et al., 1991», indicating a prerequisite role for this ion (McClelland et al., 1989). 
However, the availability of substrate (eg., casein) lowers the Ca2+ demands to approximately 5~ 
:Melloni et al., 198411991). The initial cleavage generates an 18kDa C-terminal fr;tgment 
:Crawford et al., 1993) which appears to contain the entire domain VI from the30kDa subunit 
:Nishimura et al., 1991). Simultaneously, a 78kDa subunit is detectable. Over longer periods of 
ncubation (ie., up to 90min at 25°C) 55, 34, 27 and 21 kDa fragments appear, the 34 and 21kDa 
"emnants are the major products of autolysis. The former contains all of domain II, the catalytic 
Jomain, and some of domain I. The latter embraces domain IV, the Ca2+ binding region, and about 
)0 amino acids from domain III of the large subunit (Nashimura et al., 1991). As a consequence 
)f this initial autoproteolysis, the enzyme requires lower physiological concentrations of Ca2+ for 
lctivation (Edmunds et al., 1991), and has the potential to operate in vitro. The initial self 
lctivation requires a concentration of Ca2+ approximately two orders of magnitude higher than that 
lormally present in cells (Salamino et aI., 1993). Therefore. it is reasonable to assume that a 
nechanism exists that is capable of increasing the affinity of the protease to Ca2+ in vivo. 
v1elloni et aI., (1991) has proposed an activation model (Figure 1.4) where external stimuli lead to 
ransient ri~_es in intracellular Ca2+. Under these slightly elevated Ca2+ concentrations, calpain is 
ranslocated to the inner surface of the plasma membrane where interaction with the lipid bilayer 
:ncourages a conformation change (Pontremoli et al., 1985: Gopalakrishna et al., 1985). This 
)romotes autoproteolysis at normal physiological Ca2+ levels. Cleavage of the anchoring domain 
eleases the enzyme into the cytosol. Under the translocation-activation theory cytoskeletal 
)roteins, transmembrane or intrinsic proteins, and proteins translocated to either the plasma 
l1embrane or the cytoskeletal array all become potential cal pain substrates. A second, and possibly 
elated mechanism suggests that the inactive proenzyme associates with a low molecular weight 
4OkDa) activator protein at the plasma membrane (Salamino et al., 1993). This association 
onverts the proenzyme to the low Ca2+ requiring' isoform whlch then dissociates and becomes fully 
ctive. 
8 
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Figure 1.4 Model for in vivo calpain activation (from Melloni et ai., 1991). Pro-calpain refers 
to the inactive proenzyme form. Numbers (circled) indicate activation by 1) abnormal increase 
in Ca2>; 2)low Ca2> and a digestible substrate; 3) interaction with plasma membrane; 4) 
interaction with activator protein. The e symbol denotes points at which calpastatin may 
inhibit the process. 
Understanding the calpainlcalpastatin system in vivo is complicated by the fact that both 
components (protease and inhibitor) are found in the same cellular compartments. Figure 1.4 
displays several positions in the activation model where calpastatin may inhibit calpain. For 
example, calpastatin may prevent translocation of procalpain to the plasma membrane, or the 
conversion of procalpain to calpain via the association with membrane phospholipids. It is not 
clear how, or if. calpains avoid inhibition by calpastatin, but there are a number of possibilities. It 
could be that a large quantity of calpain relative to calpastatin enables some free, unbound calpain 
to operate. Imbalances of this nature have been detected in the human pituitary (Kitahara et al., 
1986). LOca1is~on ~t the plasma membrane may sequester calpain away from calpastatin 
(Gopalakrishna et al., 1986), and formation of the enzyme-inhibitor complex may demand higher 
Ca2+ concentrations than those required for enzyme activation alone. It is, however, conceivable 
that under normal in vivo conditions cal pain is completely inhibited by calpastatin. Should 
intracellular Ca2+ concentration rise to an abnormal level then the calpains are activated excessively 
and override calpastatin inhibition. As a consequence autoproteolysis and deregulated protein 
catabolism occurs within the cytosol. Calpain II has the potential to degrade calpastatin during the 
unregulated proteolysis (Melloni et al .• 1991). 
This model of activation is not universally agreed upon. Goll et al .. (1992) has suggested that 
calpains do not bind to phospholipids at the plasma membrane. but rather the associate with 
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specific proteins such as phospholipase C-B (Banno et al., 1994). Furthermore, this association 
does not reduce the Ca2+ requirement for activation. Goll et at., (1992) suggests that regulation of 
calpain activity is achieved by Ca2+ binding to certain sites on the calpain molecule which elicits a 
variable response (eg., activation, calpastatin binding). How this system is regulated is unknown at 
this stage. Additionally, an article by Crawford et al., (1993) however, has stated that for calpain II 
to display activity, autoproteolysis is not necessary and calpain II does not exist as a proenzyme. 
Apparently, some questioQS still exist regarding calpain activation. 
1.3.3 Involvement of calpains in post-mortem tenderisation. 
There is strong evidence to suggest cal pains are involved in post-mortem tenderisation (Dransfield 
1994). Calcium is known to have catabolic effects on protein turnover (Lewis et al., 1982) and 
tenderisation can be accelerated and improved by addition of Ca2+ ions (Wheeler et ai., 1991b; 
Whipple et at., 1992). Conversely, myofibril fragmentation can be inhibited by EDTA, zinc and 
leupeptin (Uytterhaegen et al., 1994; Whipple et at., 1991; Koohmaraie I 990alI992a). Zinc and 
leupeptin both inhibit cysteine proteases. Additionally, in vivo myofibrillar changes occur in 
parallel with the activity of calpain I during the 24 hour period immediately post-mortem 
(Koohmaraie et at., 1987), and significant correlations have been reported between calpain activity 
and myofibril fragmentation (Shackelford et at., 1991). Finally, Forsberg et at., (1989) infused 
rabbits with a B-adrenergic agonist (cimaterol) and observed a corresponding reduction in 
myofibrillar protein degradation and increase in calpain activity. This has been substantiated by 
Kim et al., (1993) and Wheeler et al., (1992). Thus there is substantial evidence to indicate the 
calpain system has an important role in determining meat tenderness. 
1.3.3.1 Factors influencing the activity of the calpain system 
The amount and activity of calpains varies according to important biochemical regulators such as 
changes in Ca2+ concentrations, binding of calpain to calpastatin, inactivation of free calpain, and 
the proteolysis of calpastatin (Dransfield 1993). However, other factors such as storage conditions, 
rigor development and animal production may dictate these biochemical influences (Dransfield 
1994). With respect to animal production, little research has been performed to establish whether 
growth manipulation has an effect on the tenderness of meat or the calpain proteolytic system. 
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1.4 Biotechnology 
Currently there is a trend towards producing leaner meat in r~sponse to consumer demands 
-
(Campion et ai., 1991). Traditionally, the selection and cross breeding of animals has been used to 
manipulate growth, but recent advances in genetic engineering and molecular biology have 
provided new innovative technologies. de Vries et al., (1991) has classified these into four 
biotechnological approaclies. They are; 
• use of DNA markers: the search for genetic polymorphism which leads to 
identification of genes linked to desirable traits such as superior growth and 
development. This permits the selective breeding of animals based on genotype rather 
than phenotype; 
• improved reproduction techniques: used to increase reproduction rates, number of 
offspring per animal, and in concert with the use of DNA markers the best embryos 
from a choice of several; 
• propuction of transgenic animals: transgenic animals result from the incorporation of 
foreign genes into early embryos. This produces genetically modified offspring; 
• application of biotechnological products: administration of biotechnological products 
(eg., hormones and antibodies) to modify animal hormonal status and promote growth. 
Some important distinctions can be made between these approaches based upon their various 
advantages and disadvantages. Genetic modifications, such as transgenic engineering and selective 
breeding based upon DNA markers, are intended to make a positive contribution to the gene pool 
and are long lasting) Whereas administration of biotechnological products such as hormones and 
antibodies produce a more immediate and transient effect, are usually cheaper, and the products do 
not affect the genotype. 
-
One problem affecting all of these approaches is that there is an incomplete understanding of the 
biology of growth. Specifically, within an animal there are several complex interrelated systems 
responsible for growth and modification of one may not necessarily produce the desired phenotypic 
change. 11tis lack of understanding extends from the control of genes to the action of hormones. 
Furthermore, there are several technical difficulties associated with the reproductive biology of 
production animals such as recovery of eggs for microinjection. long gestation times and relatively 
small litter sizes of commercially important livestock such as cattle and sheep (Smith et al., 1991)) 
Whilst the creation of transgenic animals is a technology that is currently unreliable, expensive and 
has a low efficiency for producing first generation transgenic animals (de Vries et al .• 1991). 
Additionally, it is probably naive to assume that the carefully considered insertion, deletion or 
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modification of a gene will not impact on other metabolic processes. Any unintended effects must 
be identified in case they are harmful to the animal or consumer, and depending on the nature of 
the effect this confirmation can be difficult, expensive and time consuming. Finally, despite the 
potential of biotechnology there are profound moral, ethical and safety questions of public concern 
that need to be taken into account (Grandin 1991). Consequently, the application of biotechnology 
techniques must be considered carefully, and acceptability schemes employed (Lupien 1991). 
Immunomodification is a--technique included under the 'administration of biotechnological products' 
classification. It is characterised by alteration of the target animals immune system, which leads to 
further metabolic chan~es. Usually, immunomodification seeks to change an animals hormonal 
status with the intent 'of promoting growth. 
1.4.1 Immunomodification 
Pe11 et al., (1991) summarises the manner in which immunomodification may be emplpyed. 
Firstly, animals may be vaccinated against proteins such as SRIF (which inhibits growth hormone 
r 
production) in the same way humans are vaccinated against viral and bacterial diseases using an 
immunogenic fragment causing neutralisation of activity. Vaccination depends upon the 
endogenous production of polyclonal antibodies which can neutralise endogenous, or 'self, 
hormone activity. 
Next, monoclonal antibodies (mAbs) can be produced from mice which recognise specific proteins 
or peptides associated with hormone activity, injection of these into livestock animals can actually 
enhance the activity of these proteins. Similarly, the injection of peptides involved ingrowth (eg., 
the active site of growth hormone) leads to the production of endogenous polyclonal antibodies 
which can augment or potentiate the activity of the peptide in a similar manner to Mabs. 
Finally, _~ti~odies can be used to mimic hormones or peptides, and these encourage anti-antibodies 
(or anti-idiotypes) to perform as the original hormone. An anti-idiotypic response may arise 
following administration of an enhancing peptide (eg., the active site of growth hormone) to an 
animal. Because the enhancing peptide is a truncated form of the whole protein it is not recognised 
as 'self and induces the generation of antibody I (Abl) which specifically recognises this active 
site. 'This is occurrence is analogous to a glove around a hand (Holder et al., 1991). Abl now 
displays a region that is the negative of the enhancing peptide. Ab2 is generated against Abl 
molecule in a similar glove and hand fashion, this returns the negative to a positive, and Ab2 may 
then bind to the GH receptor and generate a GH-like response in the cell. 'This process is referred 
to as an anti-idiotype response (Pell et at., 1991; Holder et at., 1991). 
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1.4.2 The Growth Hormone Axis 
One facet of the endocrine system that is often targeted for ~anipulation by immunomodulation is 
the Growth Hormone Axis. This axis has direct and indirect actions on growth regulation and 
regulates the distribution of fat and protein between body tissues. 
Growth hormone (GH), Wso known as somatotropin, is synthesised by the anterior pituitary. Direct 
effects are mediated by growth hormone binding to the growth hormone receptors on the surface of 
target cells. Indirect effects are mediated by stimulating the synthesis of Insulin like Growth 
Factor's (IGF's, often known as somatomedins) which bind to IGF receptors. The effects of GH 
vary according to different tissues (Aston et at., 1991). This diversity of action is attributable to 
the differences in the structure of the GH receptor and by post-translational modifications of the 
receptor molecule. 
The synthesis of growth hormone in the anterior pituitary is under the influence of positive and 
negative regulators from the hypothalamus (Phillips 1987). The regulators have beeq'characterised 
and are called somatotropin release inhibiting factor (SRIF, a, negative effector) and growth 
hormone releasing hormone (GHRH, a positive effector). The control of GH release is also under 
the influence of negative feedback loops which inhibit GH production at the pituitary and 
encourage SRIF synthesis. The IGF's produced by GH stimulation inhibit GHRH and augment the 
activity of SRIF (Rudd 1991) and GH by down regulating GH production. 
The effects of GH were fIrst identified 50 years ago by Evans and Simpson (-1-931). In their trials, 
crude GH was repeatedly administered to rats and an increase in body weight ensued. Upon closer 
examination it was discovered that protein accretion had increased and fat deposition was reduced. 
Since this time, a list of GH effects have been reported. Notably, administration of GH to sheep, 
pigs and cattle increases growth rates (PeB et at., 1991) and reduces the lipid content of whole 
carcasses (Dawson el at., 1991; Wood el al., 1991). An increase in total muscle has also been 
observed (Pommier et at., 1990; PeB el al., 1991) in addition to diabetogenic and lactogenic effects. 
The exact mechanism by which GH effects growth remains unclear. As already noted, GH may 
operate directly upon tissues or by encouraging the production of secondary growth promoters eg., 
somatomedins. Most of the GH effects on muscle are probably mediated by IGF-l which increases 
in response to GH administration (Wallis el at., 1987). No direct effects of GH on muscle cells 
have been demonstrated but IGF-l has been shown to promote amino acid uptake, muscle ceB 
proliferation and glucose uptake. (Dawson el at., 1991) 
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1.4.3 GH and immunomodification 
Administration of exogenous growth honnone has been shown to significantly increase animal 
growth (Pell et al., 1991). However, consumer demands for wholesome products and the industry 
concern over public safety have resulted in the technique not being universally accepted, and it is 
unlikely to be used commercially (Holder et al., 1991). 
, 
In contrast, over the last 10-15 years the immunological manipulation of factors associated with the 
GH axis (GH, SRIF and GHRH) has attracted considerable attention, and mAb enhancement of GH 
action has been extensiyely studied (Holder et al., 1991). Typically, a decrease in fat deposition 
and an increase in whole body protein occurs. Additionally however, an increase in IGF-1 levels is 
observed with GH changes, suggesting that the body composition changes are taking place via 
nonnal growth pathways. Included in the list of effects resulting from immunomodification to 
augment GH are :-
.' lactogenic effects (Holder et al., 1988; Pell et at., 1989); 
• somatogenic effects (Holder et ai., 1988); 
• diabetagenic effects (pell et ai., 1989); 
• increases in serum GH (Gardner et al., 1990; Dawson et al., 1991); 
• increases in GH activity (Aston et ai., 1986; Aston et ai., 1991); 
• increases in circulating IGF-l levels (Dawson et ai., 1991; Gardner et ai., 1990; Wallis 
et at., 1987); 
• augmented growth rate and whole body protein content (Aston et al., 1991); 
• a rise in average body weight (Gardner et ai., 1990; Dawson et al., 1991; Holder et al., 
1988; Wallis et ai., 1987); 
• .. ch.aoge_s in body composition and increases in feed consumption (Holder et at., 1988); 
• reductions in body fat content (Holder et ai., 1988). 
Additionally, however, immunomodification has been employed to modify animal growth via 
targeting the regulators (SRIF and GHRH) and effectors of GH (lGF's). 
Using GHRH conjugated with human serum albumin, it is possible to induce an immune response 
against this hormone. Immunoneutralization in this way leads to a number of metabolic changes in 
cattle. Firstly, the normal episodic release of GH from the pituitary is disrupted, and the basal 
concentration and frequency of GH release was lower than that of the control animals. 
Additionally, IGF-I concentrations were reduced (Moore et al., 1992). These changes were 
reflected in a lower growth rate and final animal size. 
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Reducing the activity of GH inhibitors such as somatostatin (SRIF) has been demonstrated by 
Spencer (et ai., 1983) who found that administration of a somatostatinlhuman serum globulin 
complex to lambs induced an immune response against somatostatin. TIlls coincided with a 
Csignificantly greater weight gain and mature height in treated animals when compared to control 
animals (P<O.OOl). Increases in GH, insulin and IGF's were also noted. Weight gain was 
proportional in all tissues ie., there was no changes in body composition. In a similar study, 
immunisation against sOl}latostatin was performed by obtaining commercial somatostatin and 
conjugating this with bovine thyroglobulin (Bass et ai., 1987). TIlls adjuvant was injected into 
sheep and elicited an inimune response. The immunisation caused a small increase in growth rate 
but had no effect on body composition. No effect was seen on the plasma concentrations of GH, 
IGF-II, free fatty acids or plasma glucose but IGF-I concentrations were raised. In trials performed 
by PeB (et ai., 1991), immunoneutralisation against somatostatin induced a 76% improvement in 
whole body growth compared to globulin immunised controls. Again there was no alteration in the 
proportion of bone, muscle and fat. Experiments with protein conjugated/somatostatin in pigs has 
/ 
shown that GH levels were augmented compared to control animals (Q6breuil et at., 1989). 
However, Holder (et ai., 1991) noted that immunisation against somatostatin has generated 
conflicting results. Some papers claim an increase in GH occurs, whilst others report a drop in 
growth rate. It would appear that variables such as sex, age, breed etc have compounding effects 
on somatostatin immunisation. Indeed subsequent experiments by Pell (et qi., 1991) have not 
substantiated the preliminary trials thus immunoneutralisation against somatostatin has remained 
controversial. 
Passive immunisation to neutralise circulating IGF-I was investigated to determine how important 
its mode of secretion is in maintaining animal growth (Kerr et al., 1990). Immunisation against 
IGF-I had no net effect on body metabolism. However an increased circulating IGF-I level was 
observed. The lack of an immunisation effects suggests that local IGF-I synthesis is sufficient to 
maintain growth or that local IGF-I production is modified to maintain homeostatic levels. 
1.4.3.1 Mechanism of antibody potentiation 
There are several theories based on the above observations that attempt to explain how a GH-
antibody association leads to potentiation of GH activity. 
Firstly, it has been suggested that Mabs increase the circulating half life of GH by limiting the rate 
of normal hormone degradation (Pell et al., 1991; Kerr et aI., 1990). However, currently there is 
no correlation between this observation and the ability of Mabs to potentiate or promote growth 
(Wallis et al., 1987). 
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Antibodies may induce a conformational change in the structure of GH leading to an elevation in 
activity of GH. However, this is unlikely because Mabs specific for different regions (epitopes) of 
the GH molecule amplify the effects of GH similarly (Holder et ai., 1991). and for this to happen 
all the Mabs would have to induce favourable conformational changes in the molecule. 
The GH-antibody complex may prolong the receptor association (Holder et al., 1988) by limiting 
the normal process of receptor processing and degradation. This would reduce the receptor 
turnover and increase the intracellular signal (Holder et ai .. 1991). Alternatively, different receptors 
exist for the GH molecule and Mabs raised against GH may restrict Mab-GH binding to only some 
of the receptors. This may lead to some receptors being unoccupied and receptive to other GH 
molecules (Holder et ai., 1988). 
It is also possible that 'the Mab-GH complex binds to receptors that are more biologically active 
and as a consequence a greater growth response occurs (Wallis et ai .• 1987). This theory is called 
the "restriction hypothesis" (Aston et ai .. 1991). It is supported by evidence presented by Aston (et 
al .• 1986), EBI and EB2 are Mabs specific for different GH epitopes. Both have in vivo enhancing 
effects on GH activity but when administered in vitro to cell lines such as RLM and IM9 
lYfVphocytes. the effects on GH are inhibitory. This suggests that jJle~M:abs bind to separate GH 
receptors with different growth promoting potential. It is suggested that the differences between in 
vivo and in vitro studies may be attributed to Mabs restricting the binding of GH to distinct 
receptors. 
While the mechanism(s) by which antibody mediated growth promotion remains unclear. several 
hypotheses have been presented. All the mechanisms involve aspects of basic hormone action since 
responses to antibody treatment are analogous across various hormone experiments (Holder et al .• 
1988). 
·1.4.3.2 Immunomodulation and animal production 
Public concern over the fat content and price of meat has encouraged the development of 
technologies that are capable of increasing muscle accretion (Dawson et al .• 1991). In reality. the 
exogenous administration of GH or any other hormone will probably never be commercially 
practised due to consumer resistance and safety concerns. This is despite the fact that compounds 
such as bGH and pGH have no effect on primates and possess relatively short half lives (Aston et 
al .. 1991). A more acceptable technique is the use of immunisation to produce endogenous factors. 
such as hormone specific antibodies. which will modify the endocrine system. There are two 
important favourable characteristics of immunomodulation in commercial livestock. Firstly a 
limited number of small injections can induce a relatively large immune response. In contrast. the 
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administration of synthetic GH requires regular injections producing an acute response (Pell et at., 
1991). Secondly, if the growth effector (eg., GH active site) is successful in eliciting an immune 
response then it will stimulate the production of specific polyclonal antibodies. These may then 
bind to, and potentiate, the action of whole endogenous GH through one of the mechanisms 
described above (Holder et at., 1991). Mab complexes cannot be considered endogenous since the 
Mab probably originates from mice, consequently polyclonal potentiation may be perceived as 
being more "natural". Public education campaigns should be encouraged to illustrate the 
advantages of this technique if this technology is to be pursued further. 
1.5 Separation of the Cal pains using chromatography 
Chromatography techniques are used to separate, purify and identify compounds from a mixture of 
elements. Generally chromatography protocols involve two phases, a stationary phase and a mobile 
phase which moves over, through or around the stationary phase (Wilson and Goulding., 1986; 
Scopes., 1987). The mobile phase represents compound mixture (eg., proteins), while the former 
phase describes some sort of absorptive material to which the coropc5iinos may differentially 
associate. Many stationary phase materials are available and, usually one is selected on the basis of 
its potential to bind to a particular compound of interest and thus remove it from the mixture. 
Many common stationary phase materials operate on the principles of ionic. exchange and 
hydrophobic interaction. 
1.5.1 lon-exchange chromatography 
The underlying principle of this technique is the attraction of oppositely charged molecules for one 
another. Most proteins contain ionisable groups which furnish the molecule a net positive or 
negative charge. The matrices employed in ion-exchange chromatography present charged 
groupings to which proteins may attach (Wilson and Goulding 1986). Diethylaminoethyl Sephacel 
(DEAE Sephacel) the ion-exchange matrix used in these experiments. Its molecular structure 
includes a polysaccharide chain (cellulose) to which DEAE groups have been attached. 
Importantly, DEAE contains a nitrogen group which confers a positive charge to the matrix; this 
will associate with anions in the mobile phase. The modified molecule is correctly known as a 
weak anion exchanger (Clark and Switzer 1977) because'the net charge on the DEAE molecule is 
positive and thus its exchangeable counter ions are negative. Elution of proteins ionically bound to 
the matrix material can be achieved by changing the ionic strength or pH of the buffer washing 
through the column. 
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DEAE sephacel chromatography is a commonly employed chromatographic approach used for the 
separation of the calpain system components, and a number of studies have been performed to 
demonstrate its abilities (Koohmaraie 1990b; Wheeler et at., _1991a). Generally, tissue samples are 
prepared in buffers which contain agents to limit autolysis (eg., EDTA, EGTA, leupeptin). Care is 
taken to minimise the ionic strength of the buffer so that non-protein charged groups (eg., salts) 
will not limit the desired protein-DEAE associations. The adjustment of ionic strength of the buffer 
fulfils another useful purpose in that it standardises the initial ionic concentration at which binding 
takes place. With respett to the extraction of the calpains this is usually less than 25mM NaCI 
(Wheeler et at., 1991 a). This then permits accurate reproductions of the ionic changes required to 
elute off the desired proteins. Furthermore, a well controlled ionic strength can be used to prevent 
weakly binding material from associating with the DEAE groups even before a elution protocol is 
applied. This initial fractionation of the sample can greatly reduce the A278 absorbing material and 
make the elution profile 'cleaner'. 
1.5.2 Hydrophobic chromatography 
Phenyl Sepharose operates on the basis of hydrophobic interactions (or salt promoted adsorption 
(Scopes 1987» as opposed to ionic interactions. Proteins are generally soluble in water or dilute 
salt solutions but most contain aliphatic or aromatic amino acids that are not water soluble. The 
proteins solubility is achieved by the protein folding around clusters of hydrophobic residues, thus 
isolating them from the proteins environment. This structure is maintained by weak van der Waals 
associations, and the net energy gained from such an arrangement contributes to the overall folding 
of the protein (Clark and Switzer 1977). These internal hydrophobic groups will only be exposed 
if the molecule is disrupted in some way, otherwise the interaction with chromatography matrices 
must rely on the surface hydrophobic regions. Scopes (1987) notes that although most hydrophobic 
groups ten~. tobe held inside the molecule, substantial numbers reside on the protein surface and 
are exposed to the solvent. These are variable in number and vary in strength from protein to 
protein. The functional group of phenyl sepharose is a benzene ring, linked by glycerol ether to the 
backbone molecule, agarose. Agarose is found naturally in agar. However agar contains many 
charged and neutral groupings. These are removed in the generation of agarose to leave a 
polysaccharide molecule possessing few charged groupings. Elution is achieved by disrupting the 
structure of water and thus discouraging hydrophobic interactions or by removing agents (such as 
salt) that are augmenting the hydrophobic associations. In the former case, elution agents include 
ethylene glycol or ethanol (Wilson and Goulding 1986) or other chao trophic agents. 
Three different approaches, have been used to separate calcium dependant proteases and calpastatin 
18 
from muscle. The differences between the methods are based on the chemical attributes of the 
calpain molecules. Specifically their propensity to unfold and expose hydrophobic domains in the 
presence of Ca2+. Gopalakrishna and Barsky (1986) noted that following calpain I and II binding to 
Ca2+, they both expose a strongly hydrophobic core domain. 1bis behaviour is not unique and has 
also been witnessed in other calcium binding molecules possessing the EF hand motif eg., 
calmodulin and troponin C. 
This Ca2+ induced behaviour is exploited in Ca1+ dependant hydrophobic chromatography where 
the calpain containing extract is filtered through a column of phenyl sepharose beads. In the 
presence of CaCl2 the conformation of the molecule is altered to expose its internal hydrophobic 
regions. These then associate' with the hydrophobic domains on the phenyl sepharose beads, and 
separation from non-hydrophobic proteins is achieved. This technique demands the inclusion of a 
protease inhibitor (eg., leupeptin) to prevent the calpains autolysing in the presence of Ca2+ (Ou et 
ai., 1991; ilian and Forsberg 1992; Gopalakrishna and Barskey 1985). Furthermore, the inhibitor 
must be washed from the column before elution of the calpain fractions. Extraction from the 
column is achieved by introducing a Ca2+ chelating agent, such as EGT A, which complexes out 
Ca2+ and reverses the Ca2+ induced calpainlbead association. 
An alternative separation technique makes use of much weaker non-Ca1+ d~p.endant hydrophobic 
chromatography principle. 1bis technique takes advantage of surface hydrophobic residues which 
naturally bind to phenyl sepharose, but with considerably less affinity than those groups exposed by 
the addition of calcium. Hodgkinson and Lowry (1981) have noted that hydrophobic interactions 
generally increase with increasing ionic strength, and the addition of NaCI tOJpe calpain extract 
promotes salting out of the calpain molecules onto the sepharose beads (Gopalakrishna and Barskey 
1985/1986). Elution is achieved by successive washes which lower the NaCI concentration of the 
fluid medium. 
Difficulties exist in both the Ca2+ dependant and Ca2+ independent chromatography separation of 
cal pains and calpastatin. In the case of Ca2+ dependant techniques. the use of EGT A to elute off 
the calpains produces only a single peak of protease (Gopalakrishna and Barskey 1985) and 
separation of the two calpain isoforms requires further separation eg., DEAE Sephacel. 
Additionally, cal pains form complexes with calpastatin and other endogenous substrates in the 
presence of Ca2+. These associations can limit the binding of calpain to the phenyl sepharose 
beads. The Ca2+ independent technique employs the use of relatively strong ionic mediums (eg., 
O.5M), high NaCI concentrations which can lead to the inactivation of calpain II, even in the 
presence of protease inhibitors (Gopalakrishna and Barsky 1985; Kendall et at., 1993). These 
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complications necessitated the development of a third technique termed the routine isolation 
procedure (Gopalakrishna and Barsky 1985). This technique utilises aspects from both of the 
previous procedures .. Incubation of calpain proteins with Ca2+ and a strong ambient NaCl 
concentration promotes initial binding to the matrix. Elution of protein off the column is achieved 
by washing with decreasing NaCI concentrations in the presence of EGTA ie., Calcium independent 
elution. 
1.6 Summary 
The calpains are part of an endogenous intracellular proteolytic system found in all cells. The 
activity of these enzymes has been associated with structural changes of the myofibril during post-
mortem muscle conditioning, and currently there is a widely held view that the calpains are 
responsible for post-mortem tenderisation of meat. The use of immunomodification to augment the 
growth of livestock is a promising technique with several favourable characteristics. However, no 
researchers have yet investigated the effect of this manipuLatign upon tenderness and calpain 
/ 
a~tivity. This thesis intends to assess this question b~6sing chromatographic techniques to isolate 
the components of the calpain system, and comparing proteolytic activities with tenderness. 
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Chapter 2 
Ai ms of Present Study. 
As explained in chapter one, tenderisation is a complex multifactorial process, and several 
environmental and animal based factors influence the conditioning of muscle into meat. The 
calpain proteases, and their endogenous inhibitor calpastatin, are important biochemical factors 
, 
whose activities profoundly effect meat tenderness (Koohmaraie 1994; Dransfield 1994) and hence 
quality. At this stage our understanding of the behaviour of these proteases is incomplete, 
particularly with respect to ~eir normal physiological roles and the factors that regulate them. A 
complete appreciation of the calpain system, once developed, would enable researchers to a9vise 
producers and processors of meat how to maximise tenderness and minimise variations in 
tenderness of meat products. A solid foundation of knowledge will also enable researchers to plan 
future experiments more effectively. 
The aim' of this study is to better understand the behaviour of the calp<i!n enzyme system in ovine 
skeletal muscle. In particular, it will try to optimise methods for their extraction and quantification, 
investigate their in vivo behaviour with ageing, and their associations with parameters such as body 
composition. Five experimental chapters are included in this thesis. A brief description of the 
aims of each chapter follows: 
Chapter 3 - Comparison of methods for the extraction and measurement 
of the calpain proteases and their inhibitor calpastatin. 
This chapter evaluates several existing techniques that are used to extract and measure 
calpains--and-calpastatin. A comprehensive survey of the literature revealed that four 
distinct techniques are employed by researchers. Two of these involve hydrophobic 
chromatography and two utilise ion exchange chromatography. These techniques have 
been reproduced as described in the papers and specific elements of the protocols 
evaluated. Factors taken into consideration are the ability of the procedures to separate 
the proteases from muscle, their technical ease, reproducibility, speed of separation and 
the yield of proteases and inhibitor. 
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Chapter 4 - Development of an extraction and measurement technique 
suitable for the detection of calpains and calpastatin. 
The characteristics of a "good" experimental technique are that it is reliable and 
reproducible. However, consideration of the time involved and convenience of the 
technique should also be taken into account. The results from chapter 3 suggest a 
procedure that fulfils these requirements. This chapter relates a standardised analytical 
protocol for the extraction and measurement of the calpain system components to be 
used in later expe-riments described in the thesis. 
Chapter 5 - Characterisation of calpain activities over time in post-mortem 
ovine muscle. 
In accordance with the development of a better understanding of the calpain enzyme 
system, this experiment will investigate changes in the calpain/calpastatin system in 
tenderisation during storage of post-mortem meat. 
Chapter 6 - Differences in the activity of calpains and calpastatin in two 
lines of sheep differing in their glucose tolerance. 
Levels of circulating glucose are known to have an effect on growth hormone 
concentrations via mediation of insulin levels. This chapter examined whether 
differences in glucose tolerance, insulin levels, and body composition were reflected in 
differences in the calpain protease system. Two lines of genetically selected sheep, 
one displaying high glucose tolerance and one low, were used in this work. The 
associations between body composition and components of the calpain system were 
measured and compared. 
Chapter 7 - The effect of immunisation against growth hormone on 
components of the cal pain protease system in sheep. 
Several studies have demonstrated the potential of monoclonal antibodies specific for 
growth hormone to modify growth and body composition in a variety of animals 
including sheep. This chapter establishes whether observed differences in body 
composition, resulting from antibody mediated growth hormone modification are 
associated with changes in the calpain protease system. The use of antibodies to 
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increase animal growth has received considerable support and has important 
ramifications for the meat producing industry. No work has examined whether 
modifications of growth by growth hormone antibodies has an effect on the proteolytic 
enzymes or meat tenderness . 
.. 
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Chapter 3: 
Comparison of Methods for the Extraction and Measurement of 
the Cal pain Proteases and their Inhibitor Calpastatin. 
3.1 Introduction. 
There is now considerable evidence to support that the calpain proteases and their inhibitor 
calpastatin are involved in the conditioning of meat and may control the ultimate tenderness Of 
meat (Koohmaraie 1994; Dransfield 1994). Studies have variously implicated calpain/calpastatin 
activities, abundance, ratios and structures as being responsible for the differences in meat 
tenderness observed between individuals and species. Whatever the exact nature of the calpain 
system and tenderness, all research in this field has required reliable, reproducible and accurate 
techniques for the extraction and quantification gf the components of the calpain system. 
A variety of experimental approaches have been used to elucidate the structure of the proteins and 
observe changes in the conformation of the calpains resulting from autolysis. Other research has 
been concerned with quantification of components associated with tenderness predictors such as 
treatments (eg exogenous growth hormone), time, or species differences. In the former experiments 
purification of the native protein is demanded, and obtaining a complete yield of the protein from a 
muscle source is usually not vital. In the latter types of experiments, however, a relatively crude 
protein preparation is satisfactory and a complete quantification of the proteins is required. 
Obviously, the nature of the experiment and the information desired from the experiment dictates 
the experimental techniques used. 
In the experiments contained in this thesis, a total yield of protein from a sample is required but the 
absolute purity of the isolate is not crucial. This is because these experiments are concerned with 
revealing changes in protein activity associated with treatments and the effects of parameters such 
as time, processing, glucose tolerance and circulating growth hormone status of the animals. Thus 
the survey of techniques is limited to those whose ultimate objectives are similar. 
[n this chapter five methods of calpain extraction were compared in order to determine which 
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would be the most useful in future experiments. Four original methods were examined, each 
reproduced as described in the literature. A fifth method, which was modification of one of the 
original methods, was also examined. The five methods were judged primarily upon their 
reliability, reproducibility, and accuracy. Other factors considered were the time required for 
analysis, cost, and the labour involved. 
All approaches employ column chromatography. Techniques 1,2 and 3 utilise ion exchange 
chromatography (DEAE-Sephacel) whereas techniques 4 and 5 use hydrophobic chromatography 
(phenyl sepharose). The following sections provide a brief description of the approaches. 
~ 
3.1.1 Method 1 
This procedure was employed by Koohmaraie (1990b) in a paper designed to compare hydrophobic 
and ion exchange protocols for the extraction of the cal pain system components. The key points 
about this protocol are that tissue samples were pre~d in a relatively small volume of extraction 
buffer (3 sample volumes) containing buffering and Ca2\. chelating agents. Additionally, cysteine 
residues at the active site of the calpain protease oxidise to form intra or intermolecular disulphide 
bonds rendering the protease inactive. However, B-Mercaptoethanol reduces the disulphide bond 
and reinstate the original cysteine structures by undergoing oxidation itself. The sample was then 
diluted to lower its ionic strength and enhance proteinlbead association, before being gradually 
poured onto the top of the DEAE column. A linear gradient of NaCI gradually elutes all proteins 
binding with a strength of less than O.4M NaCl. This includes calpains and ~~ir inhibitor. 
3.1.2 Method 2 
This approach has b€en employed by Wheeler and Koohmaraie (1991 a) in a set of experiments 
intended to extract and measure both the calpain and lysosomal protease systems from skeletal 
muscle. Differences from Method I include the use of more extraction buffer for sample 
homogenisation (10 sample volumes) which dilutes the sample and increases the ratio if Ca2+ 
chelating agents to Ca2+. Furthermore, the extraction buffer uses sodium acetate as buffering agent 
and includes detergent (Triton X-IOO). Sodium acetate is included because the ultimate Ph of the 
buffer (5.8) falls beyond the range of TRIS but within its effective buffering range. Triton X-IOO 
disrupts the lipid bilayer component of the sample thus releasing membrane bound proteins, and 
lysosomal cathepsins. This follows the suggestion that calpains are membrane associated prior to 
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their activation in vivo (Gopalakrishna et ai., 1986; Melloni et al., 1991). The dilution step of 
Method 1 is replaced with dialysis which has the same effect as the dilution ie. lowers the 
conductivity of the sample. Dialysis also removes small molecular weight proteins, salts and lipids 
ie. performs a crude purification. If several samples are to be analyzed and compared dialysis in 
the same buffer will equate sample compositions and variables, such as salt content, which could 
influence the binding behaviour of the proteins, can be removed. The elution protocol has been 
modified from a linear gradient to a linear gradienUbulk elution combination. Initial fractions are 
generated from a linear gradient running from 25-2oomM NaCI. This is important because 
calpastatin and calpain I elute at similar NaCl concentrations and a shallow slope will encourage 
<r 
better separation. Thejump to higher NaCl will elute all the calpain system components remaining 
(ie., calpain II). Furthermore, this bulk wash concentrates calpain II and reduces the time and 
number of fractions collected. 
3.1.3 Method 3 
This strategy employs DEAE-Sephacel, and was used to determine the effects of nutrition on the 
calpains (Thomson et ai., 1992). In this method there was no attempt to alter the conductivity of 
the sample either through dilution or dialysis and the sample was loaded directly onto a small 
column following a filtration step. The elution step is a bulk wash process. Single column 
volume washes of equilibration buffer with 100, 200 and 400mM NaCl successively remove 
calpastatin, cal pain I and calpain II from the column. 
3.1.4 Method 4 
This protocol was first described by Gopalakrishna et ai., (1985) and was investigated as an 
isolation procedure for calpains. Hydrophobic interaction chromatography using phenyl sepharose 
was used. The specific protocol followed in this work was the "routine isolation" described by 
Golpalakrishna et ai., (1985). The sample was homogenised in 5 sample volumes of extraction 
buffer including a potent acid protease inhibitor pepstatin A (Utterhaegen et ai., 1994). Following 
sample centrifugation and filtration the matrix is added. Phenyl sepharose beads had previously 
been washed in buffer containing O.25M NaCI and leupeptin. Leupeptin is a transition-state-
analogue inhibitor of cysteine protease (Koohmaraie 1992a) and following the activation and 
conformational change of the cal pain molecule, it binds to and inhibits the protease in order to 
prevent premature autoproteolysis. Elution is a bulk process designed to sequentially remove 
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Igredients used in the binding process. 
3.15 Method 5 
bis technique is similar to the routine isolation, however, this method proceeds without any 
lhibitors (ie., Pepstatin A or Leupeptin). The inclusion of inhibitors may mask the activity of the 
roteases, and the tactics intended to remove them from the protein fraction may not be effective. 
he protocol is relatively swift, uncontrolled proteolysis should be kept to a minimum. 
iI 
.2 Methods 
3.2.1 Extraction methodology 
efer to appendices 1-5 for methods, for detailed deSCriptio~ refer to the original papers. 
~ 
3.2.2 Assay for enzyme activity 
Ie activities of calpain I and II were determined using casein as a substrate .. ,This procedure 
:termines the extent of proteolysis by measuring the peptides released from casein ie., the increase 
Am absorbance in the soluble fraction after treatment with trichloroacetic acid (TCA). 0.5ml 
Jm fractions were incubated with 0.5mI Ca2+ casein assay media (lOmM TRIS-HCl, 5mM CaCl2, 
nM NaN3, 5mglmI casein, lOmM 6-MCE, pH 7.5) for 60 minutes at 25°C, Thereaction was 
JPped by adding 1.OmI of 5% trichloroacetic acid (ice cold). The assay mixture was then 
ntrifuged at 4000rpm for 15 minutes to remove the precipitate, and the absorbance of the 
per natant was measured at 278nm. Ca2+ independent protein hydrolysis was determined in the 
me manner using EGTA containing casein assay media (lOmM TRIS-HCI, lOmM EGTA, ImM 
IN3, 5mglml casein, lOmM 6-MCE, pH 7.5). Each fraction was assayed in duplicate with each 
~ay media. 
~pastatin was assayed for by adding O.SmI of supernatant to partially purified sheep calpain II 
S Unitslgm). Following incubation with O.Sm) Ca2+ and EGTA casein assay media for 1 hour at 
°C the reaction was terminated by addition of Iml 5% TCA. Calpastatin activity was determined 
the amount by which the added cal pain II is reduced. 
ternatively, calpastatin was determined by following the heated procedure, or boiling technique 
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(Shackelford et al., 1993). Aliquots of the original homogenised sample were heated in a water 
bath for 15 minutes before being placed in an ice bath for 5 minutes. The resulting coagulated 
protein was scrambled with a glass rod to facilitate separation of the supernatant and pellet during 
centrifugation at 4000rpm for 15 minutes. Samples from the supernatant were then assayed for 
inhibitory activity as described above. 
Total yield of each protease was determined by the following equations developed by Koohmaraie 
(personal communication), and survey of the literature (Koohmaraie 1990b; Wheeler et al., 1991a; 
Ilian et al., 1992). One unit of calpain activity is defined as the amount of enzyme that catalyses 
an increase of 1.0 abSorbance unit at 278nm in 60min at 25°C. 
Equation 1: 
/ 
(No. Fractions x Average Activitylml x Fraction Size) I Sample size = Unitslgm 
- No. Fractions refers to the number of fractions with observed activity. 
- Fraction size denotes the volume of the fractions collected. 
- Sample size describes the weight of the origfnal tissue sample, this is required to 
convert the units figure into units/gm. 
- Average activitylml reports the calculated activity (abs 278nm) contained in Iml 
of fraction volume. The definition of this is described in Equation 2. 
Equation 2: 
(Average activity x Correction Factor) = Average Activitylml 
- Average activity is the sum of the activities of the fractions displaying calpain 
activity divided by the number of fractions displaying activity. 
- The correction Jactor refers to the factor by which the average activity must be 
multiplied in order to determine the activity of Iml of fraction. For example if 
oiiiy O.5ml of fraction is assayed, and the total assay volume after addition of TCA 
is 4ml, then the dilution factor is (4/0.5) = 8. It is important to calculate this factor 
because each method has different assay volumes, and correction of the activities to 
a common factor must be made to compare results. 
Convert the figures obtained from negative calpain activity to positive inhibition by subtracting 
observed activity from added activity in the fractions. 
Equation 3: 
Control Activity - Fraction Activity = Positive inhibition absorbance 
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3.3 Results 
Because of the variety of approaches used in this chapter to extract and analyze the calpains and 
calpastatin. it was easiest to subdivide this section into five subsections presenting the results from 
each methodology. A comparison of results is presented in the results summary. 
3.3.1 Method 1 Results 
A total of sixty-four 3ml fractions was collected from the DEAE Sephacel column after application 
of a linear gradient of '()-400mM N aCt. The protease acti vities of every second fraction are shown 
in Figure 3.1. Results from the assay for calpastatin are in Figure 3.2. 
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Figure 3.1 Method 1. calpain I and II. Graph showing the change in Absorbance (278nm) 
following elution and a 1 hour standard incubation. NaCl inflow concentration also shown. 
Figure 3.1 demonstrates the presence of calpain I and II in fractions 24-26 and 60-62 respectively. 
The elution profiles of these peaks bear some similarity with to other in terms of height and width. 
The proteases elute at ionic strengths of 125mM for cal pain I and 350rnM for calpain II. This was 
determined by approximating the position on the gradient line at which the calpains began eluting. 
and then extrapolating this position across to obtain an ionic value. The relatively large ionic 
difference suggests that a clean separation has taken place. 
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The equation described under section 3.2.2 require variables determined by the experiment protocol 
for calculation of enzyme activity. Table 3.1 presents these variables for Method 1. 
Calpain I Calpain II 
No. Fractions 2 2 
Fraction Size (ml) 3 3 
Sample Size (gm) 5 5 
Correction Factor 4 8 
Average Activity (278nm) 0.59 0.48 
Unitslgm 2.83 4.61 
Table 3.1 Calcw.ation of units/gm calpain I and II from Method 1. 
It is apparent from this calculation that this method has been successful in separating and 
quantifying both proteases. One unit of calpastatin is the amount of inhibitor that completely 
suppresses one unit of calpain II. A volume of calpain (with known activity) is added to the assay 
tube and reduction in this activity is interpreted as calpastatin activity. The activity of the calpain 
II used in this assay was 0.187 (abs 278nm), this is displayed in Figure 3.2 as a straight line. 
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Figure 3.2 Method 1 calpastatin. Graph showing the change in Am of fractions (eluted 
from a DEAE column) after incubation for 1 hour under standard assay conditions. Control 
describes the activity of calpain II added to each tube and is represented by a horizontal 
line. The NaCI concentration at the column inflow is also shown. 
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It is evident that at no point in this assay did the activity of the fractions drop beneath the 0.187 
threshold, this indicates that there is no measurable calpastatin activity. A possible reason for this 
-
is that the assays used made no effort to account for the intrinsic activity within each fraction that 
results from the presence of non-calpain proteins. Therefore calpastatin may have been present in 
the assayed fractions, but because non-calpain proteolytic proteases were contributing to the total 
A278 measurement in these fractions the inhibition could not be distinguished. 
The protein profile displayed in Figure 3.3 indicates a significant quantity of protein elutes from the 
column and is captured by the early fraction collection tubes. 
() 
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Figure 3 ... 3 Method 1 protein profile. Graph showing the A278 absorbance of fractions eluted 
off the DEAE Sephacel. 
3.3.1.1 Method 1 discussion 
Calpains I and II have been successfully extracted and quantified by this procedure, however this 
work has failed to determine calpastatin. The protein content of fractions collected in this method 
~ 
contributes to the total absorbance ~78 figure (Figure 3.3), and without the means to differentiate 
how much of the measured absorbance is calpain and how much is miscellaneous protein, it is 
impossible to ascertain if the calpain II added to fractions in figure 3.2 has been inhibited. For 
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example, fraction 10 may contain calpastatin and may have significantly inhibited the 0.187 units of 
calpain added. However, it may also contain high concentrations of protein absorbing at 278nm. 
TIlis protein would contribute to the overall ~b_serVea absorbance and prevent the detection of 
inhibition. TIlis problem could be overcome by measuring the absorbance of each assayed fraction 
in the presence of calpain II and EDT A. The EDT A would ensure that the calpain II remained 
inactive and the activity of this fraction following a normal incubation period would reflect non-
calpain dependent absorbance. TIlis could be accounted for in a simultaneous assay in which Ca2+ 
replaced EDTA, thus encouraging calpain activity. 
An interesting observation from Figure 3.2 is that the peak found between fractions 22 and 28 
corresponds to the calpain I peak seen in Figure 3.1. However, at this time the peak is 
approximately 2/3 rts original height. TIlis probably originates because the calpastatin assay was 
performed approximately 24 hours after the original calpain assays. In this time, calpain I may 
have undergone ~autoproteolysis and reduced itself. TIlis time dependent behaviour will be further 
examined in chapter 5. 
A final observation is that the protein peaks shown in Figure 3.3 do not coincide with the peaks of 
activity in Figure 3.1. This means that the location of the protease peaks cannot be approximated 
by examination of the protein profile. 
3.3.2 Method 2 Results 
In this method seventy-two fractions with a volume of 3ml each were collected using a linear 
gradientlbulk wash combination. Protease activities from every second fraction are slipwn in Figure 
3.4 and calpastatin data is displayed in Figure 3.5. 
Figure 3.4 is similar to Figure 3.2 in that it shows clearly the separation and presence of two peaks 
of proteolytic activity. Calpain I was eluted at an ionic strength of approximately 75mM NaCI, 
while calpain II was eluted with a wash of 400mM NaCl. The shape of the calpain I curve was 
similar in both Figures 3.1 and 3.4. calpain II curve is noticeably shorter and broader in Figure 3.4 
than the peak in Figure 3.2. 
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Figure 3.4. Method 2 calpain I and II. Graph displaying the A278 of fractions incubated for 
I·hour following standard assay conditions. Inflow NaCl concentration is also included. 
For a protein to elute off an ion exchange column a specific ionic strength must be reached. In 
Method I there is a gradual increase in the ionic strength of the elution buffer, consequently calpain 
II will remain bound until such time as the required elution concentration is reached. At this time, 
however, the protein will elute and, since the ionic strength of the column is relatively homogenous 
(and there are no pockets of differential ionic concentration) the protein will elute cleanly. In the 
second method, however, a strong 400mM wash 1s applied to the column. 111is will elute calpain 
II but because the column is formerly at 200mM NaCl (following the gradient elution). the actual 
ionic strength throughout the column will become heterogenous. This could lead to variable elution 
of calpain II and a broader shorter peak of activity. The total yields of calpain I and II are 
determined by equations 1 and 2 and are 3.73 units/gm for calpain I and 4.46 units/gm for calpain 
II. Total yield (U/g) of protease from Method 1 and 2 are similar. This will be discussed in 
Results Summary. 
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Figure 3.5 Method 2 calpastatin. Graph displaying A278 increase following fraction 
incubation for 1 hour under standard assay conditions. Calpain II activity is displayed as a 
horizontal control line, inflow NaCI concentration is also shown. 
3.3.2.1 Method 2 discussion 
Calpastatin was not successfully extracted in th..i,s experiment. At no point in the survey of tubes 
shown in figure 3.5 does the activity of the fractions drop below the added calpain II activity. The 
reduction in calpain I activity over time, observed in Method 1 appears to be confinned by this 
assay. Again the cal pain I activity has decreased in, what appears to be, a time dependent manner. 
In conclusion, this method is successful in separating and assaying calpains I and II but not 
calpastatin. Although the failure to detect calpastatin probably results from a failure with the assay 
system rather than the separation. 
3.3.3 Method 3 Results 
Method 3 generated a total of 18 fractions with 5ml volumes. The first 5 of these fractions are the 
result of a lOOmM NaCl wash intended to elute calpastatin. The next five arise from a 200mM 
wash to remove calpain I and the remaining 5 fractions represent a 400mM wash which should 
contain calpain II. Figure 3.6 contains the data from calpain assays, and Figure 3.7 include data 
from the calpastatin assay. 
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Figure 3.6 Method 3 calpain I and II. Graph showing the increase in Am of fractions 
(eluted from a DEAE column in a bulk wash) incubated for 1 hour under standard assay 
conditions. 
It is clear from Figure 3.6 that the fractions eluted with lOOmM NaCl contain insignificant 
proteolytic activity (ie., ~78 = 0.018). This was anticipated since the 100mM wash is designed to 
elute calpastatin. Fraction 2 and 3 from the 200mM wash and fraction 2 from the 400mM wash 
do, however, display calpain activity. It is likely that the fonner fractions contain calpain I and the 
latter calpain II. 
Because 'of the nature of the elution (ie. column volume washes) the activity is limited to just one 
or two fractions. A total replacement of the column fluid takes place with each wash step and is 
collected separafely.- Proteins should elute promptly at each NaCI concentration. Calculation of the 
calpain activities reveals that 2.43 Units/gm calpain I and 4.76 Units/gm calpain II were extracted. 
These activities are not dissimilar to those observed in Methods I and 2. This reinforces the idea 
that the DEAE Sephacel based methods of separation are successful in eluting all the calpain 
protease from skeletal muscle samples. 
Manifest in Figure 3.7 is a trough of activity across fractions 2,3,4 and 5. Because the activity of 
these fractions drops below the activity of the added calpain II (0.063), the fall represents a positive 
inhibition and may the presence of calpastatin over this region. 
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Figure 3.7 Method 3 calpastatin. Graph showing increase in Am of fractions from method 
3' s 100mM NaCI wash when assayed under standard conditions. Basal calpain II activity 
(control) is shown as a horizontal line. 
Calculation of Units/gm calpastatin yielded from this method was 5.18. 
3.3.3.1 Method 3 discussion 
These results provide evidence that both cal pains and calpastatin have been successfully separated 
from the. tissue sample. These results differ from the previous approaches where only calpain I and 
II were able to be measured accurately. 
3.3.4 Method 4 Results 
In these experiments a total of 6 fractions only were collected. The first fraction (1.5ml) was 
composed of the drain that passed through the column upon application of the sample. which for 
the purposes of this discussion has been called Fraction O. Fractions 1. 2. and 3 (all 2ml volumes) 
represent various wash phases designed to remove inhibitors and elements contributing to the 
association of bead and protein. Fraction 4 (4ml) elutes calpain II. fraction 5 (2ml) elutes calpain I. 
The activities from each of the fractions are in Table 3.2 and Figure 3.8. Calpastatin was 
determined by a boiling technique which required no fractionation (Shackelford et ai .. 1993). 
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I Fraction I Absorbance I 
Void Volume (1) 0.016 
2ml BufferA + .25M NaCl (2) 0.007 
2ml Buffer A (3) 0.008 
2ml Buffer A - Leupeptin (4) 0.004 
4ml Buffer B + O.IM NaCI (5) 0.004 
2ml Buffer B (6) 0.013 
Table 3.2 Method 4 protease assay. Table showing the A278 increase apparent in fractions 
incubated for 1 hour under assay conditions. The numbers in parentheses are the numbers 
denoting each fraction in the graph. 
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Figure 3.8 Method 4 protease assay. Graph showing A278 increase seen in fractions 
incubated· for 1 hour under standard assay conditions. 
Figure 3.8 shows that there is activity in all fractions including the void volume which indicates 
that a problem exists in proteinlbead association/lhiS distribution of activity means that calpain I 
and II are not cleanly eluted in fractions 4 and 5, but unselectively, at each step. It is perplexing as 
to why this should be the case and why calpain activity is detectable in fractions 0-2 which 
theoretically should contain the calpain inhibitors pepstatin A and leupeptin. Quantification of the 
calpain fractions based on the activities of the fractions which theoretically contain calpain I and II 
(ie., 1,5 and 6) is 0.52 units/gm for calpain I and 1.28 units/gm for calpain II. 
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The technique has yielded significantly smaller quantities of calpain I and II (per gram) when 
compared to Methods 1-3 despite the initial source of material being the same. Calpastatin activity 
as directly assessed after boiling to remove proteases, the units/gm yield of calpastatin was 4.02. 
3.3.4.1 Method 4 discussion 
Calpains were not effectively localised by this procedure, and their yields were significantly 
reduced when compared to methods 1-3. The proteolytic activity apparent in the void volume is 
difficult to explain since any proteases in the sample should be inactive due to the presence of 
pepstatin and leupeptin. More work is required to assess this point. The calpastatin activity is 
similar but less than that obtained from Method 3. In conclusion, this technique has successfully 
separated calpain I, II and calpastatin from muscle tissue. However, the separation of the proteases 
does not appear to limit them exclusively to their expected locations of fractions 5 & 6. 
3.3.5 Method 5 Results 
The experimental design of this method is similar to that of method 4, but excludes all protease 
inhibitors. Table 3.3 contains the activities within each fraction, which are graphically represented 
in Figure 3.9. The calpastatin data is included in the text. 
I Fraction I Absorbance I 
Drain (1) 0.013---
2ml BufferA + .25M NaCl (2) 0.012 
2ml Buffer A (3) 0.008 
2ml Buffer A (4) 0.013 
4ml Buffer B + O.1M NaCl (5) 0.021 
2ml Buffer B (6) 0.019 
Table 3.3 Method 5 protease assay. Table showing Am increase in all fractions incubated 
for 1 bour under standard assay conditions. 
Figure 3.9 illustrates that the fractions intended to contain calpains I and II have a greater activity 
than any other fraction. This differs from Figure 3.8 where the drain fraction was significantly 
greater than both calpain I and II activities, indicating a more selective separation has taken place. 
However, the problem still remains that the appearance of calpain activity is not limited to fractions 
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4 and 5 - rather it is spread over all fractions with a slight greater activity in fractions 4 and 5. 
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Figure 3.9 Method 5 protease assay. Graph of data showing the Am increase observed in 
fractions incubated for 1 hour under assay conditions. 
Again this technique has yielded significantly smaller quantities of calpain I and II compared to the 
ion exchange methods. 0.76 units/gm calpain I and 6.72 units/gm of calpain II were extracted. 
The calpastatin assay follows the protocol from Method 4 and produced 3.96 units/gm of enzyme. 
3.3.5.1 Method 5 discussion 
Overall,' the calpain' activities are higher than those observed in Method 5 probably because of the 
lack of protease inhibitors. If this is the case then it is concerning to use such inhibitors for fear of 
compromising accurate quantification of the calpains. Again the boiling technique used to isolate 
calpastatin has been successful. Calpastatin activity is almost identical to that obtained in previeus 
experiments, this lends confidence to its reproducibility and reliability. In conclusion. this method 
unselectively separates calpain I and II from muscle and calpastatin activity is measured 
satisfactorily by the boiling technique. 
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3.4 Conclusion and Discussion 
In general, the DEAE-Sephacel based methods of extraction are more successful in the separating 
calpain I, II and calpastatin compared to the hydrophobic protocol. 1bis conclusion is based on the 
observation that discrete peaks of protease and inhibitor activities are observed in Figures 3.1, 3.4, 
and 3.6. This differs from hydrophobic chromatography where all the fractions appear to contain 
greater or less proteolytic activities. The inability of methods 1 and 2 to separate calpastatin 
successfully is probably a problem that can be solved by further experimentation. The method of 
assaying calpastatin in addition to the extraction method also needs further evaluation. For 
example, the current inability to detect the calpastatin component can be solved by using the boiled 
quantification procedures employed in methods 4 and 5. 
I Technique I System Component I Units/gm I 
Calpain I 2.83 
, Method 1 Calpain II 9.22 
Calpastatin 0.00 
Calpain I 3.73 
Method 2 Calpain II 8.91 
Calpastatin 0.00 
Calpain I 2.43 
Method 3 Calpain II 9.52 
---_. 
Calpastatin 5.18 
Calpain I 0.52 
Method 4 Calpain II 1.28 
Calpastatin 4.02 
Calpain I 0.76 
Method 5 Calpain II 6.72 
Calpastatin 3.96 
Table 3.4 Table showing the total yield of calpain system components acquired from each 
of the five methods assessed in this chapter. 
A comparison of the total yield of the enzymes and the reproducibility of their yield is shown in 
Table 3.4. Techniques using DEAE are usually more consistent in separating calpain I and II. One 
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possible difficulty with DEAE is its ability to separate calpastatin. Hydrophobic chromatography 
protocols showed significantly lower yields of calpain I and method 4 gave very low levels of 
calpain II activity. The conclusion that ion exchange is superior to hydrophobic chromatography 
agrees with the results of Koohmaraie (l990b). Calpastatin figures from methods 4 and 5 are very 
similar. This is because the extraction procedures were identical and were unrelated to the 
chromatography techniques employed. In other words, DEAE based methods of extraction yield 
consistently higher activities. An accurate and reliable yield of calpastatin by DEAE requires 
further investigation. Phenyl sepharose chromatographic methods gave considerably more variable 
yields of calpain I and II, and the activities were substantially less than those obtained by the 
DEAE methods. 
With respect to time of analysis, the protocols using small column volumes and bulk elution 
technique are superior. Specifically, Methods 3, 4 and 5. The entire extraction procedure from 
these approaches takes approximately 2 hours compared to 10 hours or more by the long column 
and gradient elution techniques. Time is important since the proteins of interest have a limited life 
. ~ 
span due to autoproteolysis. Consequently, the proteases must be measured promptly to obtain 
accurate and representative quantification. In addition, the nature of future work demands that a 
number of samples be compared simultaneously. Equipment limitation in itself restricts the number 
of samples that may be analyzed. Fast analytical procedures would alleviate the severity of this 
constraint, providing the proteases and inhibitor can be separated and analyzed reproducibly. 
The final point worthy of consideration is the ease of extraction. This is a p~!.ely subjective 
comparison and is not supported by any measured parameters. Up until the column stage (ie the 
preparation, homogenisation, centrifugation) the procedures are very similar. However following 
the loading of the columns differences in the ease of the procedures can be observed. In Methods 
1 and 2" after loading of the columns little attention is required until the assay procedures. Methods 
3, 4 and 5, however, demand constant experimental overseeing since they rely on differential bulk 
elutions. Thus, the ease and speed are oppositely ranked ie., the fastest are also the most labour 
intensive and the slowest are the least. This is particularly important if a large number of samples 
are to be processed. 
In summary the DEAE protocols appear superior to the phenyl sepharose based extraction 
procedures. This conclusion is based on the yield and relative success of separating calpain I, 
calpain II and calpastatin. The fastest DEAE protocol is Method 3 but this process is also the most 
labour intensive. The phenyl sepharose protocols are fast but are unable to consistently separate 
calpain I. II and calpastatin at this time. 
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Chapter 4 
Development of an extraction and measurement technique 
suitable for the detection of the calpains and calpastatin. 
4.1 Introduction 
1his project required reliable, reproducible and accurate quantification of the enzymes in the 
calcium dependant proteolytic system. A crude protein preparation is satisfactory but a complete 
separation and quantification of the individual enzymes (calpains and calpastatin) is required. In 
agreement with Koohmaraie (1990b), chapter 3 reported that the DEAE protocols are superior to 
the phenyl sepharosechromatography in achieving the separations. 1his conclusion was based 
upon the yields and achievement of the chromatographic separation using DEAE-Sephacel. The 
caipastatin c<!.mponent can be quantified by the boiling procedure. 
'"' 
1his chapter describes an experimental protocol intended to be used in subsequent experiments. It 
is based upon the Method 1 protocol in Chapter 3 with some modifications: Method 1 protocol 
was selected over the swifter Method 3 because it appeared to be more successful in reliably 
separating calpains I and II. Two discrete peaks of proteolytic activity were seen using Method 1, 
while some doubts exist as to whether the bulk elution ionic strengths (ie., lOOmM, 200mM and 
400mM) were separating the components accurately and completely. Additionally this chapter will 
illustrate the reproducabilty of the technique, and results will be compared with those from other 
workers. 
4.2 Methods 
4.2.1 Animals 
A total of 10 ewes (Y2 Merino x 1h Texel, 15 months old, 50-60kg liveweight) were killed on the 
same day at a local meat processing plant. 
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4.2.2 Cal pain preparation and assay 
Calpains were prepared from a lOgm sample of longissimus dorsi muscle taken 20 minutes after 
death and prior to electrical stimulation. A Sgm subsample of the muscle was trimmed of visible 
fat and connective tissue, minced with scissors and a scalpel, and homogenised in S vols (2Sml) of 
cold extraction buffer (l00mM TRIS-HCL, lOmM 6-MCE, lOmM EDTA, pH 8.3) using a polytron 
homogeniser set on high speed. 1bree 30 second homogenisations were separated by cooling 
periods of 30 seconds. The homogenate was centrifuged at IS,ooo rpm for 1 hour at 4°C, the 
supernatant was decanted off and filtered through a washed glass wool/cheese cloth sandwich. 
While stirring gently, the pH of the filtered extract was adjusted to 7.S with 1M acetic acid and 
( 
then dialysed for 18 hOUrs agrunst dialysis buffer (40mM TRIS-HCL, 3mM EDTA, lOmM 6-MCE, 
pH 7.S) at 4°C. The extract was filtered through a washed, moist glass wool/cheese cloth sandwich 
and then loaded onto a DEAE-sephacel column (1.S x 20cm) which had been equilibrated with 
elution buffer (40mM TRIS-HCL, O.SmM EDTA, lOmM B-MCE, pH 7.S). The column was 
washed with 2SOml elution buffer and the bound proteins eluted by a continuous gradient of NaCl 
from 25mM to 3S0mM (120ml of each) in elution buffer. 
The activities of calpain I and II were determined using casein as a substrate as described in 
chapter 3. Briefly, 0.5ml of fractions l-SS and 0.2Sm1 of fractions 56-80 were combined with 
appropriate volumes of Ca2+ and EGTA casein (lOmM TRIS-HCL, 1mM NaN), lOmM 6-MCE, 
Smglml Casein, SmM CaCl2 or lOmM EGT A, pH 7.S) to bring the total volume up to 1.0mI. The 
mixture was incubated at 2SoC for 1 hour, the reaction stopped by the addition of 1.Oml ice cold 
5% TCA. Assay tubes were spun at 4000rpm for 15 min and the soluble digestion products in the 
supernatant measured spectrophotomerically at 278nm. One unit of cal pain activity was defined as 
the amount of enzyme catalysing an increase of 1 absorbance unit at 278nm in 60min at 2S°C. 
4:2.3 Calpastatin preparation and assay 
Calpastatin was extracted from the sample following the centrifugation step described above. A 
1ml subs ample of the extract was placed in a 9SoC water bath for 15min before being placed in ice. 
The sample was stirred with a glass rod to disperse the coagulated protein, and then spun at 
11000rmp for 5mins. The resulting supernatant was assayed for calpastatin by incubating a 250~ 
subsample of the soluble calpastatin fraction with a volume of cal pain II possessing an activity of 
0.25-0.30. Calpastatin activity is determined by the loss of activity in these tubes. 
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4.2.4 pH and Tenderness measurements 
Carcasses were aged for 24 hours (at 12°C) before loin chops were removed under normal industry 
boning conditions. Chops were vacuum packed and aged up to 2 weeks at 4°C. At this time 
tenderness was assessed using a MIRINZ tenderometer according to standard techniques (Quality 
Assurance for Tenderness May 1993 MIRINZ technical report 872, ISSN 0465-4390). Briefly, loin 
chops are trimmed to a uniform depth (40mm laterally) before being cooked in a thick walled 
plastic bag submerged in a water bath at 90°C. On reaching an internal temperature of 80°C, the 
loins are immersed in an ice bath. Randomly chosen samples of a uniform size (2cm x lcm x 
lcm) were sampled from the cooked loin. The 2cm length of the sample ran parallel to the muscle 
fibres. The section was placed in the Tenderometer and the force (Kpa) required to sever the tissue 
across the fibres recorded. Kpa was converted to kilograms force (Kgf) by Equation 4: -
Equation 4 
Kgf = (0.20116 x Kpa) - 1.1373 
pH and temperature were recorded at intervals prior to boning, and again at 2 weeks. This was 
done using a Hanna HI9025C portable meter with an Orion Ross combination spear tip pH 
electrode (81-63) and temperature probe. pH was measured in the LD muscle. Care was taken to 
ensure sampling was within a limited region of the muscle. The pH probe was standardised at 
sampling temperatures. and cleaned to remove any residual fat collected between individual 
sampling times. 
4.2.5 Statistical analysis 
Data was tabulated in Quattro Pro spreadsheets, statistical analysis used Minitab Statistical software 
package. Data was analyzed using ANOYA, Students t Test. and regression. 
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4.3 Results 
4.3.1 Calpain system components 
Animal Calpain I Calpain II Calpastatin 
1 0.05 0.41 2.66 
2 0.39 0.28 3.11 
3 0.19 0.40 3.69 
4 0.42 0.34 3.73 
5 0.57 0.16 3.35 
6 0.47 0.70 3.11 
7 0.24 0.49 2.43 
8 0.36 1.03 3.62 
9 0.16 0.36 3.29 
10 0.14 0.57 3.23 
Average 0.30 (±0.17) 0.47 (±0.25) 3.22 (±0.43) 
Table 4.1 Calpain l, II and calpastatin activities (units/gm).in LD muscle 20 min after death. 
4.3.2 Temperature, Tenderness and pH results 
Figures 4.1, and 4.2 illustrate the average changes in temperature and pH, in LD muscles from 10 
animals over a 24 hour commercialised chilling regime. Table 4.2 presents~e tenderness of loin 
chops at 2 weeks of age. 
45 
1·.-,. 
Temperature C·C) 
30,---------------------------
25 
20 .............................................. . 
:1 ••••••••.••••• · ••.•••.•••••••. · •. · ••• ·· ••••••••••• 
I 5 t- ................................................. . 
I 
O~' ----~----~--------~----~ 
o 5 10 15 20 25 
TIme (hours post-slaughter) 
- Temperature 
Figure 4.1 Temperature profile of the LD muscle stored under standard industry 
.) 
conditions up to 24 hours post-slaughter. 
pH 
6.5,.---------------------------, 
6.3 ..... . 
6.1 ........................ . ··········~l 
:::f ~~:~.::::: ~::::'::,:: ................. ':1 
5.5 '---......:...-----'------'-------'------' 
o 5 10 15 20 25 
TIme (hours post-slaughter) 
..... Average pH 
Figure 4.2 pH profile of the LD muscle stored up to 24 hours post-slaughter under 
industry cooling conditions. 
,- .",.',"',".-
46 
In Figures 4.1 and 4.2 like reductions in temperature and pH are apparent. Final pH is reached 
after 12 hours and final temperature is attained 24-48 hours post-slaughter. 
Animal I Tenderness (Kgf) 
1 8.71 
2 10.29 
3 8.40 
4 8.66 
5 10.93 
6 11.31 
7 4.29 
8 8.79 
9 7.55 
10 16.22 
Average I 9.51 (±3.1) 
Table 4.2 Tenderness values obtained for loin (LD) muscle after 2 weeks ageing. Values are 
ex~essed in Kgf. and are the average of between 4 and 8 individual samples. 
( 
Figure 4.3 shows the correlation of calpain J, II and calpastatin with tenderness within each animal. 
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Figure 4.3 Graph illustrating correlation between enzymes (units/gm) and tenderness in LD 
muscle samples. 
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It is apparent from this figure is that there is considerable scattering of both enzyme activities and 
tenderness. TItis is supported by the J! values which are not significant. There appears to be, 
however, positive correlation between the enzymes (calpain I, II and calpastatin) and toughness. 
4.4 Conclusion and Discussion 
4.4.1 Calpains and Calpastatin 
The technique employed in these experiments has been successful in extracting cal pains I and 
calpain II and calpastatin from LD muscle. Activity profiles of the enzymes show there is no 
overlap of calpain I arid II (data not shown). However, the yields of enzyme (units/gm) seen here 
are noticeably less than those determined by DEAE-Sephacel in Chapter 3 (Methods I and 2). A 
survey of current literature reveals the following trends. 
Calpain I I Calpain II 1 Calpastatin I Source 
Ovine 
0.76 1.15 1.25 Koohmaraie 1990a 
0.58 0.67 1.25 Kretchmar et ai., 1990 
1.23 1.39 2.43 Koohmaraie et al., 1991 
Porcine 
1.18 0.93 1.49 Koohrnaraie et ai., 1991 
Bovine 
.---" 
1.09 1.12 4.13 Koohmaraie et al., 1991 
1.32 0.81 3.28 Morgan et ai., 1993 
1.05 1.44 3.72 Wheeler et ai., 1992 
Table 4.3 Summary of literature presenting enzyme yields (Units/gm) measured by the same 
assay protocol used in this work, and at similar times, from LD muscles. 
There would appear to be similarity in the levels of enzymes from these various investigations. -
Calpain I and II exist in a roughly even ratio of I unit/gm, while calpastatin levels fluctuate from 
less than 1 to 4. The experiments in this thesis reflect these trends, although the absolute yields of 
protease are less than those reported in Table 4.3. TItis could be due to variation in the sampled 
material (eg., animals) or experimental techniques (eg., extraction or assay). However, it seems 
doubtful that disparity is produced by the animals since the above table lists enzyme yields from 
three different species and yet the values are similar. It is more likely that experimental protocols 
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vary in some way. 
Furthermore, it is not obvious why the protease activities in this chapter should be less than those 
reported in Chapter 3. The extraction method has been altered slightly (eg extraction buffer 
volume, gradient volumes) but not in a manner than could conceivably lead to the apparent 
differences. It is possible however, that the tissue used in Chapter 3 (which was the same for all 
the examined Methods) was not representative. This experiment has demonstrated that there are 
individual variations in enzyme activities which do not reflect the trends described in Table 4.3. 
For example, the values of calpain I and II reported from animals 1 and 8 do not reflect the 
reported 1: 1 ratio. Thus, additional samples need to be examined to establish the natural variations 
in muscle enzymes in sheep .. ' 
4.4.2 Temperature, tenderness and pH 
The temperature and pH profiles over the 24 hour post-mortem chilling period conform to the 
predicted trends for ovine muscle over this conditioning period. The temperature decline is 
directedj)y storage conditions. pH decline is indirectly influenced by temperature via its regulation 
of post-mortem glycolysis and the accumulation of lactic acid. Both temperature decline and pH 
influence enzyme activities (Geesink 1993). 
4.4.3 Correlation of enzymes to tenderness 
There is a poor correlation between muscle protease activity and meat tendert1_~ss. Figure 4.3 
shows that there is a slight positive correlation between protease level and toughness (Calpain I vs 
Kgf = 0.097, Calpain II vs Kgf = 0.065). This contradicts other work where high proteolytic 
enzyme activity has been associated with tender meat. It is important to point out that the r values 
for the c'orrelation of calpain 1111 to toughness are very low «0.005). This indicates that the 
illustrated correlation lines are poor representations of the widely scattered data points. Calpastatin 
shows a positive correlation with toughness (Calpastatin vs Kgf = 0.269). This is expected since it 
is responsible for the inhibition of the calpains and thus a reduction in proteolytic tenderisation.-
While the r value of this correlation is greater (0.07), it is not significant. This failure to 
demonstrate an association between calpain activity and tenderness illustrates that it is important to 
maximise the number of samples when analysing trends. 
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4.5 Summary 
'This chapter has revealed a number of inconsistencies with respect to the quantification of calpains 
and calpastatin. Firstly, there is a significant irregularity in enzyme levels between individuals. 
Thought must be given to maximising sample numbers and reducing this variation. Another factor 
is the differences in absolute enzyme activity yielded between these experiments and those reported 
by other workers. It is important to be confident that results obtained by one technique are 
comparable with others experimental results are to be compared. I am not certain that the protocols 
described above were performed in accordance with the work of other researchers. However, this 
methodology does give consistent separation of the proteolytic system and allows reproducible 
quantification of the activity. In order to maintain the continuity of this thesis, the protocols 
described above will be used in following chapters. 
'--
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Chapter 5: 
Characteristics of calpain activities over time in post-mortem 
ovine muscle. 
5.1 Introduction. 
It is generally accepted that the rate of meat tenderisation is dependent upon the activity of the 
calpain proteases and their inhibitor calpastatin (Dransfield 1993; Koohmaraie 1994; Wheeler et aI., 
1991a). Tenderisation begins when calpain I becomes active and attacks the Z disk component of 
the muscle fibre (Dransfield 1994). As a consequence, the toughening that takes place during rigor 
development is reduced post-rigor. Approximately 50% of tenderisation occurs in the 24 hours 
immediately post-slaughter although this depends upon the muscle pH and temperature (Dransfield 
1992b~"!i After 24 hours the rate of tenderisation tapers off and reaches a plateau (Dransfield 1994). 
Under normal post-mortem storage conditions the ultimate tenderness of a lamb carcass is reached 
within 7-14 days. These changes in tenderisation correlate positively with declines in carcass 
temperature, pH and A 1P (Whipple et ai., 1990; Koohmaraie et ai .. 1987) and with increases in 
free Ca2+ concentrations (Etherington 1991). These variables are interconnected, but one important 
relationship is between the drop in A 1P and the rise in intracellular Ca2+. Under in vivo conditions 
Ca2+ pumps are found in the sarcoplasmic reticulum (SR) and maintain home~_static intracellular 
Ca2+ concentrations. However, after slaughter, and as a result of the depletion of A 1P stores; there 
is cessation in their activity and intracellular Ca2+ rises. As a result, the activity of calpain I 
increases rapidly after death. This rise takes place within the 6-10 hour period post mortem and 
represelltsa signifieant increase over the basal calpain activities. The extent of elevation is 
dependent upon pH, temperature and the stress the animal is subjected to prior to slaughter. 
Maximum calpain I activity is realized after about 10 hours and then declines rapidly. Dransfield 
(1993) has calculated that this decline is such that only 18% of the initial levels are present at 48 
hours post-slaughter. This rapid loss of activity, coupled with increasing meat tenderness, indicates 
that calpain I is an important protease involved in the conversion of muscle into meat (Etherington 
1991 ). 
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Calpain II activity begins to increase after 16 hours, reaches a maximum by 20 hours, and then 
(~-- slowly declines over several days. The absolute maximum activity attained by calpain II is 
, 00:) significanay less than that for calpain I (Dransfield 1994), al1hough the exact activities vary from 
I / animal to animal, and between species. 'This delayed increase and reduced activity compared to 
\ / 
\/ calpain I arises for three reasons: 1) Intracellular free Ca2+ concentrations are sufficient to activate 
all the calpain I protease but will only activate 30% of the total calpain II. 2) Calpain II is 
maximally active at pH 7.5 and would therefore display only a fraction of the normal post-mortem 
storage pH of 5.5. 3) Calpain II has been found to possess maximum proteolytic activity at 20°C 
whilst most tenderisation occurs at the storage temperature of 2-4°C (Koohmaraie 1988). 
Thus tenderisation commences with the rise in activated calpain I and toughness subsequently 
declines rapidly reaching about 50-60% of the initial toughness after 24 hours. Tenderisation after 
24 hours is caused by residual calpain I and the lesser calpain II activities. The slight increase in 
tenderness after 6 days is due to calpain II only. 
The cessation of calpain I and II activities is a result of their autolysis (McClelland et at., 1989; 
Melldni et at., 1984). Under experimental assay conditions (5mM Ca2+ concentration) after 60 
minutes the activity of calpain I is only 17% as high as it was before autolysis began. Calpain II is 
only 6% (Edmunds et at., 1991). 1bis suggests that the process of deactivation takes place at an 
exponential rate (Koohmaraie 1987), and work by (Edmunds et al .. 1991) has indicated that 
autolysis of calpain II is an intramolecular process whereas calpain I autolysis is intermolecular. 
The purpose of this chapter was to examine the effect of time (post-slaughter) on calpain activities 
in vitro. Calpain activity was measured at 6 time intervals post-mortem. Following a survey of 
current literature it was decided to group these times so that the early post-mortem period (up to 48 
hours)" were" well defined. 
5.2 Materials and Methods. 
It was decided to use the DEAE Sephacel bulk elution technique (Method 3 analyzed in Chapter 3) 
on the basis of its speed of separation, and the limited drain OI"U~~Qurces. Calpastatin was not 
--------
measured. 
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5.2.1 Cal pain extraction. 
~These experiments employed a modified version of the process described by Thomson et ai., 
(1991). A whole longissimus dorsi muscle was removed from a Coopworth lamb immediately after 
slaughter, and maintained at 4°C for the duration of this experiment. The effect of 0, 6, 24, 48, 72 
and 144 hours post-slaughter storage on muscle proteases was determined. At each of these times a 
Sgm subsample of muscle was trimmed of visible fat and connective tissue, minced with a scalpel 
and scissors and then homogenised in 30ml extraction buffer (SOmM TRIS-Hcl, lOmM B-MCE, 
lOmM EDTA, and 0.2% Triton X-1OO, pH 7.S). The homogenate was spun at 32000rpm for 60 
min at 4°C and the supernatant decanted. The conductivity of supernatant was adjusted to 20mM 
using distilled deionized water then loaded onto a 1 x 20cm econo-column containing Sml DEAE 
Sephacel (pre-washed with equilibration buffet). Once the sample had drained through the column, 
the column was washed with 30ml equilibration buffer (40mM TRIS-HC1, O.SmM EDTA, lOmM 
B-MCE, pH 7.S). Subsequently the column was eluted with 6 column volumes of lOOmM NaCl in 
equilibration buffer, 6 column volumes of 200mM NaCl in equilibration buffer and 6 column 
. volumes of 400mM NaCI in equilibration buffer. A total of eighteen Sml fractions were collected. 
5.2.2 Measurements of activities 
Each fraction was assayed for calpain activity. 0.2ml from fractions 1-12 was incubated with 0.2ml 
Ca2+ casein (lOmM TRIS-HC1, SmM CaCI2, ImM NaN3, Smglml Casein, lOmM B-MCE, pH 7.S) 
for 60 minutes at 25°C. The reaction was stopped by adding O.4ml ice cold 5% (TCA). The assay 
mixture was centrifuged at 4000rpm for 15 minutes to remove the precipitate and the absorbance of 
the supernatant was measured at 278nm. This measurement reflects the amount of protein 
hydrolysed by Ca2+ dependent proteolysis under these standard assay conditions. The Ca2+ 
independent hydrolysed protein was determined in the same manner using EGT A containing casein 
(lOmM TRIS-HCl, lOmM EGTA, ImM NaN3, Smglml Casein, lOmM B-MCE, pH 7.S). Each 
fraction was assayed in duplicate with each assay media. For fractions 13-18, O. I ml of the fraction 
was incubated with each of casein medium and the Ca2+ dependent activity of each fraction was 
multiplied by 2 to produce results comparable with those for fractions 1-12. Calculation of calpain 
I and II activities (units/gm tissue) were performed using Equations 1 and 2 in Chapter 3. 
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5.3 Results. 
5.3.1 Experiment 1 
Table 5.1 and Figure 5.1 show activities of skeletal muscle calpain I and II decline with time. 
o Hours 6 Hours 24 Hours 
.. Calp I Calp II Calp I Calp II Calp I 
No. Fractions 1 2 3 2 2 
Fraction Size (ml) 5 5 5 5 5 
Sample Size (gm) 5 5 5 5 5 
Average Activity 1.76 1.59 0.42 1.48 0.29 
(per ml, 278nm) 
Units/gm 1.76 I 3.18 1.26 I 2.96 0.58 
48 Hours 72 Hours 144 Hours 
CalpI Calp II CalpI Calp II Calp I 
No. Fractions 1 2 . 1 2 1 
Fraction Size (ml) 5 5 5 5 5 
Sample Size (gm) 5 5 5 5 5 
A verage Activity 0.10 1.70 0.11 1.21 0.12 
(per mi. 278nm) 
Units/gm 0.10 I 3.40 0.11 I 2.42 0.12 
Table 5.1 Activities of calpains I and II (units/gm tissue) from post-mortem muscle at six 
sampling periods. Also included are the variables required for their detennination. 
I 
, 
I 
Calp II 
2 
5 
5 
-
1.64 
3.28 
Calp II 
2 
5 
5 
0.84 
1.68 
It would seem from Figure 5.1 that calpain I levels drop more rapidly than calpain II. This 
observatioILagrees with that reported by Koohmaraie et at .• (1987). After 48 hours calpain I 
activity is only 6% of the original whereas calpain II still retains over 53% of its initial activity at 
14 hours. 
Time (Hrs post-mortem) 0 6 24 48 72 144 
Calpain I 1.76 1.26 0.58 0.10 0.11 0.12 
Percent of Time 0 100 72 33 6 6 7 
Calpain II 3.18 1.26 3.28 3.40 2.42 1.68 
Percent of Time 0 100 93 103 107 76 53 
Table 5.2 Activity (units/gm) of calpain [ and II in post-mortem muscle over 144hr period. 
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Figure 5.1 Calpain activities decile with time. Calpain I and II levels in LD muscle stored 
at 4°C. Calpains were extracted using a DEAE bulk elution method, and assayed following 
standard assay procedure. The graph includes the hypothetical position of the 1% for 
calpain 1. 
In concordance with the results of other workers (Edmunds 1991; Dransfield et ai., 1992b) the rate 
of calpain I decline appears to be exponential. The time frame of the decay is, however, faster than 
has been reported else where. 
5.3.1.1 Discussion 
Table 5.2 iridicaTes that 50% of calpain I activity is lost between 6 and 24 hours post-mortem. The 
extrapolated line in Figure 5.1 approximates the 'f1h of calpain I to be IS hours. This differs 
markedly from Koohmaraie et ai., (1987) who observed that a 50% drop in calpain I only occurred 
after 24 hours. Breed and muscle differences in the levels and activities of the cal pains have been 
previously observed (Ouali et al., 1990). The muscles used in Koohmaraies' work were LD taken 
from cattle, and this may explain the observed contrast. The decline in calpain II is more gradual 
than calpain r. The 'f1h of calpain II is estimated at 7-10 days which is sooner than that reported 
by Koohmaraie et al., (1987). Koohmaraie estimated that by 14 days, 80.2% of the original calpain 
II was present which equates to a 'f1h of more than 1 month. 
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Interestingly, the activity of calpain II escalates between 6 and 48 hours post-mortem, after which 
the activity tapers off in a near linear trend. The increase in calpain II agrees with other work 
(Dransfield 1994) and possibly results from increased availability of Ca2+. No drop was observed 
in calpain II in the initial 24 hour period in agreement with Koohmaraie et al., (1990a). A 
relatively rapid drop to 76% of the original activity was seen between 48 and 72 hours after which 
time the decline levelled off. 
5.3.2 Experiment 2 
Another experiment was conducted to assess the changes in calpain activity over the initial 5 hour 
post-slaughter period. The experiment was performed as previously described in the Materi,als and 
Methods section at 1, 2, 3,4, and 5 hours post-mortem. Figure 5.2 displays the results graphically 
and tables 5.3 and 5.4 the individual data. 
, 
1 Hour 2 HOUTS 3 Hours 
Calp I Calp II Calp I Calp II CalpI Calp II 
Units/gm 1.54 I 3.28 1.25 I 3.32 0.90 I 3.50 
4 Hours 5 Hours 
Calp I Calp II CalpI Calp II 
Units/gm 0.71 I 3.28 0.76 I 3.18 I 
Table 5.3 Activities (units/gm) of calpains I and II from post-morteiJi" muscle at five time 
intervals post-slaughter. Cal pains were extracted following a DEAE based bulk elution 
technique, and assayed under standard conditions. 
Confirmi,l!~ o~ earlier work there was a significant drop in the activity of calpain I in the initial 5 
hour period post-mortem. There was little measurable changes in calpain II activity. 
5.3.2.1 Discussion 
In Figure 5.1 the 1112 for calpain I was approximately 15 hours. In the previous experiment the 'Ph 
is hypothesised to be between 3 and 4 hours post-mortem. This difference is probably .due to 
sample variation since the storage and measurement conditions were the same in both experiments. 
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Figure 5.2 Variation in calpain I and IT activities in the LD muscle over five hours post-
mortem. Muscle was stored at 4°C for the duration of the experiment Graph includes the 
hypothetical position of the T1f2 for calpain I. 
There are two possible explanations for the results. Firstly, it may be that sample 2 had higher 
intracellular Ca2+ levels which would accelerate autolysis of the calpain I protease. Usually 
however, animals maintain relatively stable homeostatic levels of ions such as Ca2+, and therefore 
this is probably an unlikely explanation. Secondly, the slaughter conditions may have caused the 
fIrst animal to suffer more stress which would raise its post-slaughter pH. Calpain I has a pH 
optimum of approximately 7, and higher pH possibly retards its activity. This could then appear as 
a reduced activity in vivo and a lower rate of self proteolysis. 
Time (Hrs post-mortem) 1 2 3 4 5 
Calpain I 1.54 1.25 0.90 0.71 0.76 
Percent of Time 0 100 81 58 46 49 
Calpain II 3.28 3.32 3.50 3.28 3.18 
Percent of Time 0 100 101 107 100 97 
Table 5.4 Tabulated results showing units/gm of calpain I and II over time. Percentage 
changes (when compared to time 0) is also displayed. 
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5.4 Conclusion and Discussion 
-
The bulk elution (Method 3 in Chapter 3) appears to have been successful in extracting the calpain 
proteases. The reliability of this protocol was assessed in this experiment (data not shown) by 
simultaneously performing three extractions on samples of meat taken from the same muscle. 
Calpain I and calpain II were separated, and the enzyme yields from each column were within 5% 
confidence interval. 
As noted in the results section, there is a relatively rapid drop in both calpain I and II in these 
experiments compared to the results presented by other researchers. It is difficult to be certain of 
the reasons for the differences but it may be due to variations in the experimental protocol or in the 
tissue samples analyzed. In this work the same muscle from different sources was compared. 
Different TW s were observed despite a uniform experimental protocol. This evidence alone 
supports the hypothesis that differences in samples can lead to differences in the characteristics of 
~e proteases. 
~" 
The observations on the time dependent decline of calpain activity in these experiments agree with 
those made by other workers (Koohrnaraie et at., 1987; Dransfield 1992b) .. Total activity of 
calpain I fell rapidly post-mortem, whereas calpain II levels remained relatively stable before 
gradually declining. Post-mortem muscle pH fell from 6.7 to 5.5 due to the conversion of 
anaerobic respiration converting glycogen into lactic acid. This in tum leads to the formation of 
cross bridge links between the muscle thick (myosin) and thin (actinTl1laments and the generation 
of tough meat (Etherington 1991). However, rigor development is temporary and the muscle enters 
into a tenderisation stage once certain criteria (such as rise in Ca2+) are met. The conditioning stage 
represents the conversion of muscle to meat. The rapid drop in calpain I, seen in Figure 5.1, 
reflects its action in the conditioning process. As the A TP content in the muscle tissue declines, 
the activity of the Ca2+ pumps found in the sarcoplasmic reticulum (SR) slows to a halt. This, 
coupled with proteolytic attack of the SR, leads in an inability of the Ca2+ pump to maintain 
homeostatic Ca2+ levels and a significant rise in Ca2+ becomes apparent. Soon after death the -Ca2+ 
ion concentration is approximately 1O-7M in the sarcoplasmic reticulum, which is too low to 
activate the calpains and their inhibitor. However, after the pH of the muscle tissue has dropped to 
about 6.1 the Ca2+ concentration rises to 104 M which is enough to maximally activate some of the 
muscle calpains (Dransfield 1992). Calpain I is activated and proteolytically attacks the Z disc of 
the muscle myofibril. This leads to a fragmentation of the fibrillar structure and an overall 
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tenderisation of the meat product Koohmaraie (1988) has determined despite the presence of a 
substrate Z disc, that the calpains also execute self destructive autolysis which leads to 100% 
- -
degradation of the calpains. Thus the actual activity of calpain I in the conditioning process is 
mirrored in self destructive autolysis and its overall decline. Thus just as calpain I degrades the Z-
disc it also degrades itself. 
Calpain II appears to maintain a relatively high activity (units/gm) during the first 48 hours post-
mortem. The fact that there is little change in the units/gm during this time suggests that calpain II 
is not undergoing autolysis and is not especially active in the tenderisation process. After 48 hours, 
Figure 5.1 showed a decline in the amount of calpain II extracted from meat. This decline is 
caused by the protease undergoing autolysis. It is likely that there are two reasons for this delayed 
activity. Firstly the free Ca2+ reaches 100% after approximately 24 hours (Etherington 1991) and 
this high level of Ca2+ is demanded for the activation and operation of calpain II. However, 
because calpain I is still present in sufficient concentrations to sequester the free Ca2+, calpain II 
remains relatively inactive. It will remain inactive until levels of Ca2+ are 100% and until calpain I 
has undergone autolysis and released the Ca2+ it was sequestering. Once calpain II becomes active 
\ . 
it pIUticipates in the conditioning process by degrading the Z-disc component and also undergoes 
intermolecular autolysis (Edmunds et al., 1991) which is responsible for its gradual decline. This 
has been shown in Figure 5.2. 
The increase in calpain II activity at 24 and 48 hours is puzzling. Two suggestions may explain 
this. Firstly, it may be that more cal pain II is being extracted from the musc~~_tissue, and secondly. 
the calpain II being extracted may be more active at these intermediate times (24-48 hrs) than when , 
fresh. There have been a number of papers suggesting that for reasons of enzyme activation, 
calpain II binds to components (protein or lipid) of the plasma membrane (Pontremoli et al., 1985; 
Salarnino et ai.;-1993). During the extraction process a centrifugation step is used to remove 
plasma membrane lipid and it is possible that calpain II bound to the membrane is also discarded. 
As the muscle tissue ages, sources of energy (eg .. A TP) responsible for maintaining the cellular 
integrity dissipate and a loss of cell structure takes place. This loss of structure is probably 
displayed as plasma membrane fragmentation and the liberation of integral components. Therefore, 
it may be that as the tissue ages calpain II is freed from the membrane and not lost during the 
separation stage. However, this explanation does not seem very likely since Triton X-IOO (a 
biological detergent) is included in the extraction buffer and should be able to completely fragment 
the plasma membranes during tissue preparation. A reason why calpain II might be more active at 
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intermediate times can be explained by the theory that calpain II binds to a membrane bound 
calpain activator protein (Salamino et at., 1993). TItis protein promotes the autoproteolysis of the 
proteinase at Ca2+ levels near physiological levels. In fact, the activator protein decreases the Ca2+ 
concentration required for activation of calpain II by approximately 100 times. Thus it seems 
likely that as free Ca2+ levels rise (post-mortem) there is a mechanism that promotes the conversion 
of inactive procalpain II to the active isoform. TItis would reflect as an increased calpain II activity 
yielded from the tissue. 
The gradual decline in calpain II taking place in the later times seems likely to be due to the 
intramolecular process of autolysis that Edmunds et al., (1991) has previously described. Again, it 
should be pointed out that the autolysis of the calpain enzyme requires its activation, and the 
observation of a rapid decline also reflects the enzymes proteolytic action on cellular components. 
Although calpastatin levels were not determined in this work, a number of other experimental 
papers have established the nature of its behaviour in muscle tissue post mortem. Whipple et at., 
(1990) reported a 50% decrease in calpastatin activity (from fresh muscle) between 0 and 24 hours 
post-mortem. She proposes that the reason for this decline is that activated calpain hydrolyses the 
inhibitor molecule. However, calpastatin can be degraded by several thiol proteinases found in 
muscle post-mortem. Dransfield (1993) determined that calpastatin decline is rapid, and has 
calculated that the decline leaves only 30% of the original activity at 24 hours. He agrees that the 
decrease is probably due to calpain mediated hydrolysis. Koohmaraie et at., (1987) concluded that 
calpastatin was very susceptible to degradation post-mortem, and that after 24 hours only 20.7% of 
the original inhibitor activity was present. By 6 days the activity was virtually eliminated. 
5.5 Summary 
TItis chapter has explored the changes in the activity of calpain proteases post-mortem. The 
conclusion is that calpain I is the most responsible for the tenderisation of meat, and that most of 
this tenderisation (and concomitant calpain I decline) takes place early in the conditioning process. 
Calpain II is probably involved only in residual tenderisation and does not decline rapidly post-
mortem. Although not measured, calpastatin is reported to drop very rapidly probably as a result of 
Calpain I hydrolysis. These observations have important implications for understanding the 
mechanistic model for tenderisation. TItis work emphasises that when quantifying components of 
the calpain system post-mortem careful consideration of the time effect must be made. There have 
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been various attempts to stabilise the system components including freezing and incorporation of 
protease inhibitors but a reliable protocol for storage has remained elusive. 
Future work in this area would benefit from experiments taking into account all the relevant factors 
mentioned here. These would include quantification of the cal pain I, calpain II and calpastatin, and 
measurement of tenderness, pH, Ca2+, ATP levels pre- and post-slaughter. 
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Chapter 6: 
Differences in the activity of calpains and 
inhibitor calpastatin in two lines of sheep 
differing in their glucose tolerance. 
6.1 Introduction. 
At Lincoln two lines of Coopworth sheep have been bred which exhibit differences in glucose 
tolerance. These animals were derived from an original flock which was screened for its tolerance 
to glucose using the glucose tolerance test (GTI). The GIT consists of a rapid infusion of glucose 
into the venous blood system which induces an insulin response. The then causes a decline in 
plasma glucose. The time (in minutes) for half the glucose load to be removed from circulation is 
referred to as T1h, and is a measure of an animals tolerance to plasma glucose. In early 1987 the 
T1h'of 350 Coopworth ram animals were determined. From this flock seven ram animals 
displaying the lowest T1h (fast glucose clearance) were termed Fast sires, and the seven with the 
highest T1h (slow glucose clearance) were called Slow sires. Each ram was mated with 25 mixed 
age Coopworth ewes allocated at random. Rams from the resulting progeny (generation 1) were 
screened as before and then mated with a new flock of ewes. This process was repeated a second 
and third time to produce second and third generation progeny. By early 1990 these matings had 
given rise to 2 flocks of sheep with significant differences in their tolerance to glucose. Sue 
Francis (1990) wrote a comprehensive PhD thesis which examined the physiological differences 
between the two lines of sheep. Her experiments concluded that the Slow line animals had a 
significantly (p<O.05) slower rate of glucose clearance than the Fast line. The resting plasma 
glucose was significantly (p<0.05) higher in the Slow animals than Fast animals. Resting insulin 
levels did not significantly differ. However, following a glucose challenge the level of plasma 
insulin was significantly higher (p<0.05) in the Fast than Slow sheep. Body composition 
differences were apparent in an examination of subcutaneous fat depth over the 12th rib at the GR 
position. Fast animals displayed significantly greater depths of subcutaneous fat than the Slow. 
Concordantly, the percentage of fat in the whole carcass was significantly (p<0.05) less in the Slow 
than the Fast line. The same trend was observed for the depth of the longissimus dorsi (LD) 
muscle. The Fast line of sheep had significantly (p<0.05) greater LD depth than the Slow. 
Unexpectedly. the total carcass protein was significantly greater in the Slow than in the Fast sheep. 
Francis (1990) pointed out however. that the muscle depth measurements made at one site on one 
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muscle may not reflect the pattern of the whole muscle mass. Plasma urea, which reflects protein 
degradation, was lower in the Slow than the Fast line. Another muscle parameter of interest is pH, 
and other researchers (Shorthose 1970) have observed a positive correlation between 'fIh and 
muscle pH. This would suggest that Fast animals may have a higher muscle pH than Slow. 
However, in her work, Francis (1990), observed there were no significant pH differences between 
the two lines of animals. Table 6.1 summarises these observations. 
Slow (Long T1f2) Fast (Short T1f2) 
Glucose clearance rate Lesser Greater 
Resting plasma glucose Greater Lesser 
Resting plasma insulin No difference No difference 
Glucose challenge plasma insulin Lesser Greater' 
Subcutaneous fat Lesser Greater 
% Fat (whole body) Lesser Greater 
Muscle depth (longissimus dorsi) Lesser Greater 
~ Protein (whole body) Greater Lesser 
Plasma Urea Lesser Greater 
.. 
Muscle pH No difference No difference 
Table 6.1 Table showing trend of differences between Fast and Slow glucose clearance 
Coopworth sheep (adapted from Francis 1990). 
6.1.1 Physiological effects of insulin 
Insulin is secreted by the pancreas in response to plasma glucose levels and consequently is 
concerned with maintaining homeostatic plasma glucose levels. Three primary anabolic function of 
insulin are the sequestering of glucose, lipogenesis and protein deposition in muscle (Willis 1990). 
Insulin inhibits gluconeogensis and increases the peripheral uptake of glucose by stimulating the 
translocation of glucose transporter molecules (GLUT's) to the cell surface (Kahn 1985; Kasanicki 
el ai., 1990). In addition, insulin inhibits hepatic glucose output, encourages glycogen synthesis 
and alters the availability of glucose precursors to the liver (Brockman 1986). 
The lipogenic effects of insulin results from its stimulation of lipoprotein lipase (LPL), and its 
inhibition of hormone sensitive tissue lipase. Anti-lipolytic effects include reduced glycerol release 
and the reduced availability of glucogenic amino acids to the liver (Brockman 1986). 
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Muscle tissue represents a major protein store. Insulin increases the rate of amino acid uptake into 
muscle, raises the concentration of RNA and promotes the aggregation of polysomes (Charles 
1986). These actions serve to promote protein synthesis, but it is thought that this alone does not 
account for the observed increase in protein levels. It has been suggested that insulin may have a 
depressive effect on muscle protein degradation which leads to a net increase in protein deposition 
(Doherty 1992; Francis 1990). However, there is some disagreement since an increase in total 
protein may arise from either a decrease in protein degradation and/or an increase in protein 
synthesis. Thus the appropriate modification of either of these parameters could produce a net 
increase in protein content. Indeed, some researchers (Brockman et al., 1986; Weeks 1986) have 
concluded that insulin promotes protein synthesis and depresses degradation. Other workers have 
observed a decline in protein synthesis and a greater decline in degradation (Charles 1986; Oddy et 
al., 1987). Some workers have concluded that there is an increase in both protein degradation and 
synthesis, with the former increase being out weighed by the latter (Crompton et al.. 1987). 
Thus. the manner in which the balance of protein degradation and synthesis is disrupted (leading to 
a I).et increase in protein levels) is unclear. but depression of proteolysis is conceivably responsible 
for this change. The calpain proteolytic system is common to all animal cells and may be 
~ 
responsible for a significant portion of the protein degradation witnessed in muscle tissue. It has 
been stressed previously that a better understanding of the calpains and their inhibitor should be 
developed in order to fully appreciate their potential role in nutrient partitioning (Bickerstaffe 
1993). This trial was performed to determine if previously reported physiological differences 
arising from differences in glucose tolerance were correlated with changes in the calpain protease 
system and. more specifically, to investigate if the observed differences--in protein content (Table 
6.1) were related to differences in the activity of components of the calpain system. Previous 
experiments have shown that the Slow animals have a greater percentage body protein and lower 
plasma urea. It is possible that this may be the result of a depressed proteolytic system. 
6.2 Methods. 
This trial was designed to assess the effects of glucose tolerance on the calpain proteases and their 
inhibitor calpastatin. Other parameters such as body composition and insulin levels were also 
measured. Calpain and calpastatin activities were determined by ion exchange chromatography as 
outlined below. pH was measured using a Hanna Hl9025C pH meter with standard temperature 
probe, and an Orion 8163SC combination spear tip pH probe. Shear force of 40mm chops from I 
hour LD muscles was determined using a Tenderometer (B.R.Homersham Ltd) and following 
MRINZ specifications. 
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6.2.1 Animals 
-The animals used in this experiment were offspring from previously established High and Low 
glucose tolerance sheep lines. The average birth date of the animals was September 1st 1992. 
Variation around this time was 1 week. Animals within the High and Low lines were balanced for 
sex. 64 animals were maintained for the duration of the trial at the Templeton Research Station, 
Canterbury. Animals were kept on pasture and weaned according to normal practice. There was 
no restrictions on feed consumption at any time. Slaughter of the animals took place in the last 
week of March 1993. For convenience, the animals were randomly allocated to one of three 
groups. The fIrst group was slaughtered on Monday, the second Wednesday and the last on Friday. 
6.2.2 Calpain system separation and assay 
Cal pains were prepared from 40gm sample of the longissimus dorsi muscle taken from 20 ram 
animal~ (10 High, 10 Low), 20 minutes after death. A 5gm subsample of the muscle was trimmed 
of visible fat and connective tissue before minced with scissors and a scalpel. The sample was then 
homogenised in 5 vols (25ml), of cold extraction buffer (lOOmM TRIS-HCI, lOmM f3-MCE, lOmM 
EDTA. pH 8.3). Homogenisation took place in a 250ml Waring Blender cup. using a Waring 
Blender set on high speed. Three 30 second homogenisations were separated by cooling periods of 
30 seconds. The homogenate was centrifuged at 15,000 rpm for I hour at 4°C, the supernatant 
decanted off and filtered through a washed glass wool/cheese cloth sandwich. The pH of the 
filtered extract was adjusted to 7.5 with 1M acetic acid and dialysed for 18-hours against dialysis 
buffer (40mM TRIS-HCI, 3mM EDTA, lOmM f3-MCE, pH 7.5) at 4°C. The extract was fIltered 
through a washed, moist glass wool/cheese cloth sandwich and then loaded onto a DEAE-sephacel 
column (1.5 x 20cm) which had been equilibrated with elution buffer (40mM TRIS-HCL, 0.5mM 
EDTA. fOmtvff3-MCE, pH 7.5). The column was washed with 250ml elution buffer and the bound 
proteins eluted by a continuous gradient of NaCI in elution buffer from 25mM to 350mM (120ml 
of each). 
Calpastatin was extracted from the sample following the above centrifugation step. A 1 ml 
subs ample of the extract was boiled at 95°C for 15min before being spun at 11000 rpm for 5rnin. 
The resulting supernatant was assayed for calpastatin. 
The activities of calpain I and II were determined using casein as a substrate. Briefly. 0.5ml of 
fractions 1-55 and 0.25ml of fractions 56-80 were combined with appropriate volumes of Ca2+ and 
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EGTA casein (lOmM TRIS-HCl, ImM NaN3, lOmM B-Mercaptoethanol, 5mg/ml Casein, 5mM . 
CaC12 or lOmM EGTA, pH 7.5) to bring the total volume up to l.Om!. The mixture was incubated 
at 25°C for 1 hour and the reaction stopped by the addition ~f 1.0ml ice cold 5% TCA. Assay 
tubes were spun at 4000rpm for 15 min and the soluble digestion products in the supernatant 
measured spectrophotomerically at 278nm. One unit of calpain activity is defined as the amount of 
enzyme catalysing an increase of 1 absorbance unit at 278nm in 60min at 25°C. 
Calpastatin was assayed by incubating a 250J1l subsample of the soluble calpastatin fraction with a 
volume of calpain II possessing an activity of 0.25-0.30 units. Loss of activity in these tubes, when 
compared with control (calpain only), represents calpastatin activity. 
6.2.3 Glucose tolerance test 
Glucose tolerance tests were performed at 20 weeks. For a GTT a single shot of glucose 
(0.3mg/kg liveweight) in 50% saline solution was injected into the jugular vein using a butterfly-
winged infusion set. Blood samples were taken into evacuated blood collecting tubes at -10, 0, 10, 
20, 40, 60 and 90 minutes relative to the glucose challenge. The blood was centrifuged for 20 
" minutes at 1000g, and plasma stored at -20°C until analyzed for glucose and insulin. 
6.2.4 Carcass measurements 
At 26 weeks measurement of hot carcass weight and subcutaneous fat over the 12th rib at the GR 
position were made at Templeton. One half of the carcass was retained and frozen for subsequent 
mincing and carcass analysis of total fat and protein. 
After slaughter, loins from both sides of the carcass were cut into 40mm chops to yield 8 chops per 
animal. The chops were stored at 1°C and at 0, 4, 8, 10, 12, 22, 30, 40 and 627 hours post-
slaughter pH and tenderness were measured using a MIRINZ tenderometer and following standard 
procedures (Quality Assurance for Tenderness Revision of MIRINZ Rm 126 technical report, May 
1991 MIRINZ 872. ISSN 0465-4390). 
6.2.5 Statistical analysis 
Data was tabulated in Quattro Pro spreadsheets before being analyzed using Minitab Statistical 
Software. Data was analyzed using ANOY A and Students T Test. 
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6.3 Results. 
6.3.1 Calpain system quantification 
The protocols described have been successful in achieving the separation and quantification of 
calpain I and II. Figure 6.1 shows two clearly defined peaks of protease activity. Table 6.2 
presents the units/gram of calpains I and II extracted from the tissues, and Table 6.3 the units per 
gram calpastatin. 
A total of 20 animals were examined. There was some irregularity in the location of each peak, 
but this is probably due to differences in individual fraction collector characteristics rather than 
separation properties. 
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Figure 6.n}raph of protease activity taken from the longissimus dorsi from one Fast "fIh 
animal. Fractions were obtained from a 20 x lcrn DEAE Sephacel column using a linear NaCI 
gradient (25-350mM), 80 3ml fractions were collected. Assays were performed following a 
standard assay protocol. 
Table 6.2 presents the units per gram calpain I and II in each sample. Calculation of units per 
gram are as described in chapter 3. 
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Animal Number '[112 Calpain I (Units/gm) Calpain II (Units/gm) 
1 Slow 1.12 0.72 
2 Slow 0.52 1.24 
3 Slow 1.07 0.52 
4 Slow 0.99 0.30 
5 Slow 0.72 0.40 
6 Slow 0.86 1.00 
7 Slow 0.69 0.88 
8 Slow 0.57 0.60 
9 Slow 0.43 0.88 
10 Slow 0.32 0.24 
Average Slow 0.73 (±0.3) 0.68 (±0.3) 
11 Fast 1.26 1.12 
12 Fast 0.55 2.42 
13 Fast 1.03 0.78 
14 Fast 0.51 0.50 
15 Fast 0.83 1.06 
16 Fast 1.12 1.38 
17 Fast 1.46 0.94 
18 Fast 1.42 0.86 
19 Fast 0.91 1.18 
20 Fast 1.52 0.58 
Average Fast 1.06 (±0.4) . 1.08 (±0.5) 
Table 6.2 Units/gm yield of calpain I and [l from 20 Coopworth rams differing in glucose 
clearance '[1/2. 
The activities of calpain I and II show considerable variation between samples from the same line 
and between lines of animals. In addition, calpain units/gm are less than those obtained in previous 
chapters. Calpain I and calpain II yields from the Fast are significantly (p<O.05) higher from the 
Fast than Slow line. 
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Animal Line Calpastatin Animal Line Calpastatin 
(Units/gm) (Units/gm) 
1 Slow 0.45 11 Fast 0.21 
2 Slow 0.14 12 Fast 0.15 
3 Slow 0.37 13 Fast 0.20 
4 Slow 0.07 14 Fast 0.07 
5 Slow 0.10 15 Fast 0.10 
6 Slow 0.18 16 Fast, 0.09 
7 Slow 0.37 17 Fast 0.03 
8 Slow 0.30 18 Fast 0.03 
9 'Slow 0.27 19 Fast 0.09 
10 Slow 0.04 20 Fast 0.12 
Average Slow 0.23 (±0.1) Average Fast 0.11 (±0.06) 
Table 6.3 U/gm Calpastatin extracted from Coopworth Rams with different glucose clearance. 
Table 6.3 shows that the activities are significantly (p<O.05) higher in the Slow than the Fast line. 
6.3.2 Glucose tolerance test 
As expected, there are significant differences between the two lines of sheep to their glucose 
tolerance. Changes in plasma glucose, with respect to time, after a single injection of glucose are 
shown in Figure 6.2. The insulin response to the glucose infusion is shown in Figure 6.3. 
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Figure 6.2 Changes in plasma glucose concentration following a glucose challenge of 3mg/kg 
body weight. Graph shows differences between High and Low glucose tolerance sheep lines. 
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Figure 6.3 Changes in plasma insulin concentration against time following a glucose challenge 
of 3mg/kg body weight. The graph shows differences between the High and Low glucose 
tolerance sheep lines. 
Table 6.4 presents the area under each curve for the glucose and insulin response curves following 
glucose infusion. The Fast line had a significantly lower concentration of plasma glucose and 
higher plasma insulin than the Slow. 
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Fast Slow 
Glucose 598.1 677.1· 
Insulin 85.3 63.7· 
Table 6.4 Area under the glucose curve and insulin response curve after a glucose tolerance test 
(P<0.05). 
6.3.3 Carcass composition 
Some of the carcass and noncarcass parameters measured at slaughter are shown in Table 6.5. 
Fast Slow 
Body gain (kg) 24.7 24.7 
Carcass protein (%) 33.3 36.0 
Carcass fat (%) 55.9 52.6· 
GR (rnm) 15.7 12.1" 
Table 6.5 Various carcass and noncarcass parameters measured from sheep with High and Low 
responses to glucose (P<0.05). 
Thus, selection for Slow glucose clearance was associated with significantly less carcass fat. 
Carcass protein was not significantly different. Thus while animal growth was the same between 
the two lines (with respect to weight gain) the body composition indicates that the Slow glucose 
clearance animals are leaner than the Fast. 
6.3.4 Meat characteristics 
Figures 6.4 and 6.5 show pH and kgf of chops (loins) from lambs at various times post-slaughter. 
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The tenderness and pH profiles shown in Figures 6.4 and 6.5 are typical of meat stored post-
slaughter. There are no significant differences between High and Low lines of sheep with respect 
to either pH or tenderness. 
6.4 Discussion and conclusions 
The experiments described in this chapter were motivated by the observation that sheep with 
differences in glucose tolerance differed in body composition and certain metabolic parameters. 
Specifically, sheep with Slow glucose clearance (high T1h) had a lower fat content and a greater 
percentage of protein (ie. were leaner) than their Fast counterparts. This agrees with earlier 
experiments using the same sheep lines (Francis 1990). Insulin is possibly the most important 
peptide hormone in the partitioning of nutrients between tissues (Prior et al., 1982; Bickerstaffe 
1993; Hart 1983; Brockman et al., 1986). It seems reasonable to suggest that the dissimilarity in 
glucose tolerance and body composition may originate from differences in the insulin status of the 
two lines of animals. Francis concluded that following a glucose challenge, Slow animals release 
less insulin than the Fast. This is responsible for the slower glucose clearance and is possibly due 
to differences in the sensitivity of the pancreas to glucose. In addition, in the basal state, the Slow 
~, . 
animals possessed more insulin receptors than Fast. This was demonstrated by the higher turnover 
rate, and the greater glucose utilization and the sensitivity to insulin of the Slow animals. The 
question remains, how do differences in insulin status affect changes in body composition? This 
chapter is concerned with exploring the possibility that insulin modifies protein degradation in 
skeletal muscle by altering the activity of the calpain proteases and their inhibitor, calpastatin. 
6.4.1 The effects of insulin in ruminants 
Insulin is primarily involved in the maintenance of glucose homeostasis in all animals and has 
anabolic' effects-on metabolism (Brockman 1986a). It is apparent from a number of studies that 
ruminant animals are less sensitive to the effects of insulin than nonruminants (McDowell 1983). 
The increment in plasma insulin resulting in a 50% reduction in glucose production is 50-60I1U ml- I 
in ruminants. The comparable value in humans is 30l1U m}"1 (Brockman et al., 1986). It is thought 
that these differences probably result from differences in intermediary metabolism particularly that 
of glucose (Janes et al., 1985). In sheep, insulin promotes the absorption of glucose into peripheral 
tissues such as fat and muscle (McDowell 1983; Brockman et al., 1986) resulting in a depression of 
plasma glucose (Call et al., 1972). In 1989, Carter et al., (1989) selected pigs on the basis of 
backfat depth and bred two distinct lines, one with high backfat depth and the other with low_ 
Following a glucose challenge, the high backfat animals had significantly elevated plasma glucose 
73 
levels over a time period of 2.5 - 7.5 minutes and higher plasma insulin concentrations. Because 
the higher backfat animals were less able to remove plasma glucose, despite having greater plasma 
insulin levels, the authors suggested that this may be due to a reduction in the sensitivity of 
peripheral tissues to insulin. Indeed, Weekes (1986) reported that significant differences exist in 
the extent to which insulin can promote glucose absorption into different tissues and that skeletal 
muscle is the most sensitive tissue. 
Liver gluconeogenesis is the main source of glucose in ruminants. Ruminant animals are forced to 
use sources of insoluble carbohydrate, such as starch, pectin, cellulose and hemicellulose, for their 
primary energy source (Atlas 1989). Formation of mutualistic relationships with rumen bacteria 
permits fermentation reactions converting these substrates into fructose-6-phosphate (Brown 1988). 
TItis in turn is converted to pyruvate and then to volatile fatty acids (VFA's) such as acetate 
(Matthews et at., 1990; Brockman et al., 1986). The VFA's are used as gluconeogenic substrates, 
and in the liver are metabolised into glucose (Willis 1990). Insulin inhibits liver gluconeogenesis 
and reduces glucose production (McDowell 1983; Brockman et aI., 1986). Some substrates for 
glu.coneogenesis may be derived from mobilised skeletal muscle. The release of these glucogenic 
substrates is inhibited by insulin (Hart 1983), Glucagon opposes the effects of insulin and 
profriotes gluconeogenesis (Brockman et al., 1986; Hart 1983). It may be that regulation of 
gluconeogenesis relies upon the ratio of insulin to glucagon rather than on the level of either 
hormone alone (McDowell 1983). 
Diet has significant effects upon glucose metabolism and most insulin effects can be altered by 
changing the nutritional status of animals. In general, fed animals are tess responsive to changes in 
insulin than their fasted counterparts, although it has been reported that in the fed state, insulin 
levels in a sheep hindlimb rise and adjustments in metabolism occur (Prior et at., 1984). However, 
this is questioned by Oddy et at., (1987) who observed no variation in protein metabolism of fed 
lambs infused with insulin. Conditions of undernourishment, however, lead to a net loss of skeletal 
muscle in the hindlimb (Lomax 1987) resulting from a 62% decrease in protein synthesis and a 
29% increase in degradation. Refeeding ad lib restores the original protein balance by depressing 
protein degradation and promoting synthesis. Oddy et at.,(1987) reported that fasting induces net 
protein loss but observed that the reaction of fasting lambs is to initially reduce protein degradation 
and later depress synthesis. 
The three main components of the adult animal are bone, skeletal muscle and fat. Fat has the most 
variable growth rate (Weekes 1983). Insulin has the potential to modify the hypertrophy (growth) 
of adipocytes but not their hyperplasia (proliferation). In keeping with the anabolic effects of 
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insulin, it is apparent from some studies that elevated insulin levels result in lipogenesis (McDowell 
1983) and antilipolysis (Brockman et at., 1986). Genetically leaner breed of pig have been shown 
to be less sensitive to the antilipolytic effects of insulin (Wood et at., 1977). The stimulatory effect 
~-of insulin on lipogenesis was lower in lean rats compared to obese (Carnie et at., 1979). As 
already noted, the experiments performed by Carter et at., (1989) that high backfat sheep had 
significantly elevated plasma insulin as well as fat content. However, these observations are 
doubted by Vernon (1986) who reported that although adipocytes in sheep possess insulin receptors 
with similar quantities and properties to those of the rat, ruminant tissues have failed to respond to 
insulin. He suggests that the duration of insulin exposure is important in eliciting physiological 
responses, and that effects from chronic exposure are more perceptible. Weekes (1986) concurs 
and indicates that it is difficult to demonstrate, in vitro, stimulatory or antilipolytic effects of insulin 
on tissue slices or isolated adipocytes. The available evidence caused Prior et at., (1982) to suggest 
that glucose may be more important than insulin in the stimulation of lipogenesis. 
Protein synthesis is thought to be positively influenced by insulin. TIlis is determined by 
measuring the flux of amino acids within a closed metabolic system such as the hind leg. This is a 
region of the animal where blood flow can be monitored accurately. By quantifying amino acids, 
~, 
such as leucine, valine, isoleucine, lysine and tyrosine (Prior et at., 1982) the protein status of an 
animal can be estimated. A net reduction in the plasma content of amino acids leaving the limb 
indicates that partitioning of amino acids into protein has occurred, and a increase suggests 
degradation. Insulin's anabolic effects on protein metabolism include stimulation of amino acid 
uptake as indicated by a fall in plasma levels (Call et at., 1972; Brockman et at., 1986), a rise in 
protein synthesis (Crompton et at., 1987) and an increase in RNA/DNA synthesis (Buttery 1983) by 
insulin. In sheep this stimulation is particularly apparent in skeletal muscle. However, Oddy et at., 
(1986) reported that several studies have expressed difficulty in demonstrating these positive effects 
of insulin in sheep. For example, in lambs 5-6 weeks old, there was no correlation between plasma 
insulin and pr61dn- synthesis. This maybe due to the insulin resistance during the early growth 
phase. However even in weaned lambs there is a very poor correlation (Vincent 1984 - Cited by 
Oddy et at., 1986). 
The levels of circulating urea provide evidence of the degree of protein degradation that has taken 
place (Hill et at., 1989) since urea is a nitrogenous byproduct of protein degradation. Call (1972) 
reported that in sheep given an acute infusion of insulin, the plasma urea concentrations did not 
change. This observation is supported by Weekes (1982) who infused sheep with insulin and 
glucose for 9 days but observed no significant change in nitrogen excretion despite a modest rise in 
insulin levels. However. in the high and low backfat sheep. the high backfat animals (high insulin) 
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demonstrated significantly higher plasma urea levels (Carter et al., 1989). It is possible, therefore, 
that for insulin to modify proteolysis and hence urea levels, a chronic disruption to insulin status is 
required. It is also possible that the lower plasma urea concentrations apparent in the lean animals 
(low backfat) may indicate more efficient use of amino acids for protein synthesis. 
6.4.2 Assessment of the Calpain system 
The first objective was to determine if techniques used in this experiment were successful in 
separating the components of the calpain system. Figure 6.1 provides the enzyme activity profile 
from one of the 20 animals examined. The assay detected proteolytic activity which corresponded 
to that expected for cal pain I and II. This indicates that the activities of these enzymes have been 
quantified effectively from the tissue samples. There is some irregularity with the location of the 
activity (data not shown) but this is probably due to using different fraction collector machines. 
However, another irregularity that cannot be explained is the significant variation in calpain 
activities, between and within lines of animals. Tables 6.2 and 6.3 show that the standard 
vaIjations are proportionately high (eg., the SD for calpain II both in Fast and Slow sheep lines is 
approximately 50% of the mean). It is difficult to explain this without more information, but there 
• j 
are a number of possible reasons. One possibility is that the initial 64 sheep were killed on three 
different days and environmental factors such as temperature, feed. and stress. varied between the 
days and led to fluctuations in protease levels. However, analysis of variance to compare the 
calpains and calpastatin among the three kill days, showed no significant trend, indicating that the 
variable kill day did not have a significant effect on the calpain levels. A second possibility is that 
the differences vary according to the sampling position of the muscle. Work from this laboratory 
has suggested that there may be variations in enzyme levels within the longissimus dorsi 
(unpublished data) and this could well account for the observed differences. A final possibility is 
that the slaughter of the animals was carried out at the Templeton Research Station rather than 
under industrial conditions. Efforts were made to ensure accurate repetition of the processing at 
Templeton but time delays were inevitable. Following the observations made in Chapter 5, care 
was taken to remove samples at the same times relative to exsanguination. However some 
variation was observed and may contribute to the observed variation in enzyme activity. All 
protocols at Lincoln were uniform. Other work carried out in this laboratory has also found 
significant variations in enzyme levels from similar sheep even when industrial processing was 
used. This suggests that the observed variation is an inherent variation and that lowering of the 
standard deviation could be achieved only by sampling more animals. Significant variations in 
calpastatin levels was apparent. 
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It has been reported in this trial that sheep with a fast insulin response have a lower percentage of 
whole body protein. Although not measured in this experiment, Francis (1990) reported that urea 
concentrations were elevated in the Fast line of sheep. These two observations suggest that protein 
c_ degradation may playa key role in nutrient partitioning into skeletal muscle. For this reason the 
calpain proteolytic system was measured in both selection lines. Significant differences were found 
between the selection lines with respect to both calpain enzymes and their inhibitor. Calpain I and 
II were significantly (p<0.05) higher and calpastatin significantly (p<0.05) lower, in the Fast than 
the Slow line of sheep. Thus it would appear that selection for glucose tolerance selects for calpain 
mediated proteolysis. This has important implications for developing a better appreciation of 
ruminant metabolism. Because control animals were not included in this trial, it is difficult to 
know whether the reported,enzyme levels are elevated or depressed relative to a normal animal. 
For the purposes of this discussion I will assume that control enzyme levels would lie between the 
values reported here. 
Other studies have revealed a positive correlation of plasma insulin to urea (Francis 1990; Carter et 
al., 1989; Bremmers et at., 1988), where insulin is chronically elevated. In this experiment it 
seems reasonable to suggest that this could be due to increased calpain activity. 
6.4.3 Glucose tolerance testing 
The trends observed in Figures 6.2 and 6.3 are entirely consistent with those reported by Francis 
(1990). A higher 'fIh, in the Slow animal line, indicates a slow glucose clearance. This could be 
due to differences in the sensitivity of the pancreatic B cells to glucose, and/or the peripheral 
sensitivity of tissues to glucose. Accurate assessment of basal plasma insulin and glucose was not 
included in this trial, but in earlier work Francis reported no significant differences in insulin levels. 
But elevated plasma glucose in the Slow animals. Raised plasma insulin levels appeared to be 
notably lower-in the Slow animals compared to Fast at 10. 20 and 40 minutes after a glucose 
infusion and divergence was still apparent at 90 minutes. This deviates from Francis (1990) who 
reported that after 60 minutes the difference had almost disappeared. However, she does not 
specify the concentration of glucose employed in her experiments and it is possible she infused less 
glucose/kg thus making the reestablishment of basal glucose and insulin swifter. Overall, the 
plasma insulin levels are lower in the Slow than Fast animals. Concordantly, glucose levels are 
lower in the Slow than Fast sheep following glucose infusion with the most obvious differences 
being apparent at 10, 20 and 40 minutes. 
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6.4.4 Body composition 
Selection of sheep on glucose tolerance has resulted in phenotypic differences other than inherited 
'fIh parameters. From Table 6.5 it is clear that sheep selected for Slow glucose clearance have a 
significantly reduced fat content and GR (subcutaneous fat) depth. Whole body protein content 
was elevated in the sheep but not significantly. There was no whole body weight gain differences 
between lines, so any partitioning imbalance is compensated by another. Thus, it would appear that 
the Slow sheep are leaner than the Fast. This conclusion concurs with that found by Francis 
(1990). Differences in body composition usually result from modification of peripheral tissue 
metabolism. It has already been noted that the Slow line of sheep have depressed levels of calpain 
proteases in skeletal Ihuscle. This could account for the greater percentage protein and illustrates 
that the changes in the protein degradation system rather than protein synthesis could be 
contributing to the differences in the observed net protein deposition. The higher fat content of the 
Fast line of sheep is possibly due to augmented insulin response. 
6.4.5 Meat quality 
~. 
There are no significant differences in pH or tenderness between the two lines of sheep. The trends 
in Figures 6.4 and 6.5 are consistent with those seen in meat from nonselected animals. It may be 
anticipated that the Fast sheep. with their higher protease and lower inhibitor levels, may have 
tenderised sooner then the Slow. There were no apparent tenderness differences. Only during the 
8-30 hour post-slaughter storage meat was there a tendency for the Fast sheep to be slightly tougher 
than the Slow. The final tenderness (Kgf) at 627 hours post-slaughte(showed no differences 
between the lines. 
6.5 Summary 
Leanness is an important quality characteristic in meat animals. and techniques to improve leanness 
have potential commercial applications. In particular, physiological markers for genetic merit such 
as 'fI/2 for lean meat could reduce errors of prediction and permit the selection of breeding stock. 
Several studies have endeavoured to support this approach (Carter et af .. 1989; Bremmers et al., 
1988). The observations made in this experiment acquiesce with the observations made by Francis. 
Specifically the Slow line of animals (Lean) had a higher area under the glucose clearance curve, a 
smaller area under the insulin response curve, reduced carcass fat, and increased protein. Possibly 
coupled with this latter observation was a significant reduction in the muscle protease activities 
(Calpain I and II) and an increase in calpastatin activity. It is possible to hypothesise that there is 
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an association between the changes in calpain activities and net protein deposition. There were no 
differences in pH or tenderness in longissimus dorsi muscles between the two lines of animals. 
'-The results raise a number of questions. Firstly, is the calpain status of the fat animals responsible 
for their lower protein content? Why would their metabolism seek to partition nutrients into fat 
rather than protein when feed is not a limiting factor? Why do animals with measurably greater 
levels of insulin (post glucose challenge) have less whole body protein when insulin supposedly 
promotes protein accretion? How does the selection for glucose tolerance lead to the altered 
calpain status? Is it because insulin stimulates cal pain gene expression Gust as it does other genes 
(Meisler et al., 1989»? Or has the selection for genes regulating glucose tolerance selected genes 
regulating calpain expression? Weekes (1986) states that the effects of insulin on phenotypic traits 
(eg fat/protein accretion) must be treated with care, and that insulin must not be considered in 
isolation but rather in relation to levels of other circulating hormones (eg growth hormone, 
glucagon), metabolites and neural inputs. Also, why do differences in calpain status not reflect in 
differences in other meat quality characteristics eg., tenderness? In conclusion, this work has 
served to emphasise the complex nature of nutrient partitioning in ruminants. It has also 
demonstrated that selection of animals on one phenotypic quality can modify others. These 
associations are incompletely understood. 
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Chapter 7 : 
Effect of growth hormone vaccine on calpain proteases and meat 
quality characteristics. 
7.1 Introduction. 
Improvement of animal production by administration of hormones is under pressure from the public 
and authorities as the image of 'hormone free meat' becomes increasingly appealing. Over the past 
20 years immunological methods for manipulating animal growth have been researched, and 
various technologies are now available for experimental use. This trial investigates the technique of 
injecting sheep with an immunogenic fragment of ovine growth hormone, specifically the active 
site. In theory this region of the molecule should elicit an immune response in the treated animals, 
and polyclonal antibodies specific for this fragment of growth hormone will be raised. These 
antibodies subsequently bind to the active site of endogenous growth hormone and potentiate its 
biological operation. This response cumulates in augmented activity of the endogenous growth 
f..j 
hormone and is reflected, physiologically, in increased muscle growth and adipolysis. Previously 
this technology has been shown to improve growth rate (Aston et al .. 1991) wool production 
:Spencer et al., 1983) and milk production (Pell et al., 1989) in sheep. Other parameters 
~onsidered in this work are growth, body composition, muscle protease activities, meat pH and 
enderness. 
7.1.1 Growth hormone and growth 
30dy growth in mammals is regulated by a blend of genetic, nutritional and endocrine factors. The 
~ndocrine system has a major impact on both growth and development of an organism (Millard 
[989). Growth hormone (GH) the is principal hormone associated with growth. 
me growth promotive effects of GH were first recognised in the classic work of Evans and 
jimpson (1931) who demonstrated that chronic administration of crude bovine GH increased the 
veight gain of rats. Later it was identified that the weight gain arose from an increase in protein 
.ccretion and a decrease in fat deposition (Lee et al., 1934). Since this time the effects of GH on 
epartitioning nutrients have been observed in a number of reports (Brockman el al., 1986; Buttery 
983: Bass et al .. 1989). 
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The consequences of exogenous GH administration on protein metabolism appear to be primarily 
associated with postabsorptive use of nutrients (Boyd et ai., 1989). Frequently, the effects of GH 
are divided into two classes, termed 'direct' or fuel regulation and 'indirect' or growth stimulation 
~effects (Ballard et ai., 1993) see Figure 7.1. 
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Figure 7.1 Schematic representation of GH effects on fuel regulation and growth promotion 
(From Ballard et ai., 1993). 
Responses to fuel mobilisation include repression of glucose utilisation, lipogenesis, amino acid 
uptake and increased lipolysis. The important point is that these effects cannoLbe likened to 
growth; but represent wasting. The second series of responses (indirect) are induced by GH and 
lead to growth promotion. They include glucose and amino acid uptake, protein synthesis, cell 
Jroliferation, and possibly inhibition of protein degradation. Figure 7. I shows that many of the GH 
!ffects are contesting. Thus the relative strength of either arm will determine the observed effect of 
:JH. Generally, however, the overall effect of GH is to partition energy into growing tissues (Bass 
~t ai., 1989). The following sections describe in more detail some effects. 
;lucose uptake - GH is influential in maintaining glucose homeostasis in both ruminants and 
rronogastrics (McDowell 1983). However, whether its effects are direct (eg., promoting 
luconeogenesis) or indirect (eg., sparing peripheral glucose utilization) is unclear. What is 
pparent is that the relationship between GH and plasma glucose is negative. Bassett (1974) 
!ported a, rapid decline in GH following an equally rapid rise in insulin in lambs ingesting milk. 
urthermore. GH appears to antagonise some effects of insulin. For example increases in plasma 
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fatty acids are often witnessed following GH infusions. Further, when animals are selected on the 
basis of fatness (eg., backfat depth), a negative correlation with GH is typically seen (Weekes 
1983). 
Cell proliferation! differentiation - GH promotes the conversion of fibroblast cells (undifferentiated 
cells) into mature adipocytes (Hausman et al., 1989). 1his direct effect of GH is coupled with 
stimulation of IGF-I which then acts as a mitogen and promotes multiplication of the differentiated 
cells. 1his twin effect of GH is called the Dual Effector Theory (Bass et al., 1989), and has also 
been witnessed in GH mediated chondrocyte and myoblast differentiation in vitro (Bass et al., 
1989; Spencer 1989). With respect to the latter cell type, however, Dayton et al., (1989) argues 
that while chronic administration of GH promotes muscle accretion, there is no evidence to suggest 
that it promotes myoge'nesis or postnatal muscle growth. Dayton et al., (1989) states that several 
studies have shown no effect of GH on proliferation or differentiation in cultured satellite cells, 
myotubes or embryonic myoblasts. IGF-I, however, has been shown to stimulate proliferation and 
differentiation in these. cells. Therefore, rather than GH having direct effects on proliferation and 
differentiation it may be that much if not all of muscle growth is mediated through IGF-I in 
response to GH. 
Protein synthesis and degradation - It is generally accepted that the main action of GH on protein 
met~bolism is anabolic (Buttery 1983). For example, Snell dwarf mice are genetically 
hypopituitary, and the administration of bovine GH to these mice leads to a significant increase in 
muscle weight (Pell et at., 1992). Seemingly this is due to a 50% increase in protein synthesis 
(Ks) as detected by the incorporation of radiolabeled phenylalanine into muscle. In turn, the 
stimulation was probably due to increased RNA content and efficiency of protein synthesis when 
expressed as grams of protein synthesised per gram of RNA per day. Martinez et al., (1991) has 
also witnessed a significant increase in the rate of protein synthesis in response to GH. In this case 
GH infusion into fasted female rats produced a 25% increase in muscle Ks within 40 minutes. In 
times of energy deficit (such as during lactation) the role of GH is thought to preserve body protein 
by promoting protein synthesis and inhibiting proteolysis (Hart 1983). With respect to proteolysis, 
there is evidence to suggest that GH has the potential to effect nutrient partitioning by altering 
protease activity. Plasmin (an enzyme protease) is detectable in mammary tissues in late lactation 
and probably has a role in tissue remodelling (Bickerstaffe 1993). Both IGF-I and bovine GH 
inhibit plasmin secretion and in so doing alter the partitioning of nutrients between mammary and 
peripheral tissues. More direct evidence comes from a study where cathepsin A activity (units/gm) 
was significantly elevated (Martinez el al., 1991) in response to GH. Further, in a study performed 
)y Pell et al., (1992) on GH treated Snell dwarf mice, the body protein content at death was less 
han expected from the increase in Ks brought about by GH. 1his implies that muscle protein 
1egradation might have increased, and account for this difference. 
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Thus, the reported effects of GH on ruminants and non-ruminants are diverse. Most researchers 
agree that GH promotes lean growth in adequately fed ruminants. Certainly from the perspective of 
the meat industry, the most interesting and important potential of GH is the partitioning of nutrients 
away from fat into muscle tissue (Bass et al., 1989). This experiment intends to measure changes 
in metabolism arising from the use of GH peptide, and its effects on the calpain system and other 
meat parameters (pH and tenderness). 
7.2 Methods. 
7.2.1 Animals 
Sixty-four animals were maintained over the trial period at the Templeton Research Station, . 
Canterbury. Animals were kept on pasture and weaned according to normal practice. There were 
no restrictions on feed consumption at any time. Slaughter of the animals took place in the last 
week of March 1993 when they were 32 weeks of age. For convenience, the animals were 
randomly allocated to one of three kill groups. The first group was slaughtered on Monday, the 
second Wednesday and the last on Friday. 
~ 
7.2.2 Trial Design 
The 64 animals were divided into two groups of 32 based on sex and into two further subgroups of 
16 (treated and untreated). Allocation of animals into the treatment groups was random. The 
peptide used in this trial corresponded to a biologically active region of GH between amino acids 
122-164. Peptide was administered in a single shot irrespective of live weight at 8, 12 and 16 
weeks. These times were chosen to maximise GH activity at the time of fat deposition (16 weeks 
+). Control lambs were injected with Freund's adjuvant only. 
7.2.3 Calpain system separation and assay 
Calpains were prepared from 40gm sample of the longissimus dorsi muscle taken from 20 ram 
animals (10 Immunised, 10 Control), 20 minutes after death. A 5gm subsample of the muscle was 
trimmed of visible fat and connective tissue before being minced with scissors and a scalpel. The 
sample was then homogenised in 5 vols (25ml). of cold extraction buffer (lOOmM TRIS-HCl, 
lOmM B-MCE, lOmM EDTA, pH 8.3). Homogenisation took place in a 250ml Waring Blender 
cup using a Waring Blender set on high speed. Three 30 second homogenisations were separated 
by cooling periods of 30 seconds. The homogenate was centrifuged at 15,000 rpm for 1 hour at 
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4°C, the supernatant decanted off and filtered through a washed glass wool/cheese cloth sandwich. 
The pH of the filtered extract was adjusted to 7.5 with 1M acetic acid and dialysed for 18 hours 
against dialysis buffer (40mM TRIS-HCl, 3mM EDTA, lOmM B-MCE, pH 7.5) at 4°C. The 
extract was filtered through a washed, moist glass wool/cheese cloth sandwich and then loaded onto 
a DEAE-sephacel column (1.5 x 2Ocm) which had been equilibrated with elution buffer (40mM 
TRIS-HCL, 0.5mM EDTA, lOmM B-MCE, pH 7.5). The column was washed with 250ml elution 
buffer and then the bound proteins eluted by a continuous gradient of NaCI in elution buffer from 
25mM to 350mM (l20ml of each). 
A sample to be tested for calpastatin content was extracted from the sample following the 
centrifugation step described above. A Iml subsample of the extract was boiled at 95°C for 15min 
before being spun at 11000 rpm for 5min. The resulting supernatant was assayed for calpastatin. 
The activities of calpain I and II were determined using casein as a substrate. Briefly, 0.5ml of 
fractions I-55 and 0.25ml of fractions 56-80 were combined with appropriate volumes of Ca2+ and 
EGTA casein (lOmM TRIS-HCI, ImM NaN}, lOmM B-Mercaptoethanol, 5mglml Casein, 5mM 
CaCl2 or lOmM EGTA, pH 7.5) to bring the total volume up to 1.0ml. The mixture was incubated 
.' at 25°C for 1 hour and the reaction stopped by the addition of 1.0ml ice cold 5% TCA. Assay 
tubes were spun at 4000rpm for 15 min and the soluble digestion products in the supernatant 
measured spectrophotomerically at 278nm. One unit of calpain activity is defined as the amount of 
enzyme catalysing an increase of 1 absorbance unit at 278nm in 60min at 25°C. 
Calpastatin was assayed by incubating a 250M! subsample of the soluble calpastatin fraction with a 
volume of calpain II possessing an activity of 0.25-0.30 units. Loss of activity in these tubes, when 
compared with control (calpain only) represents calpastatin activity. 
7.2.4 Carcass measurements 
Two weeks after the last immunisation, blood samples were collected from all animals for antibody 
assay. Animal live weight was measured from the beginning of the trial and every 3 weeks 
thereafter. 
At 22 weeks the animals were intravenously injected with synthetic hGRF (human growth hormone 
releasing factor) at O.3J.lg/kg live weight. Blood samples were collected at -15, 0, 5, 10, 15, 20, 30, 
~5, 60, 90, and 120 minutes relative to the injection and assayed for GH. 
At 26 weeks measurement of hot carcass weight and subcutaneous fat over the 12th rib at the GR 
. 
position were made at Templeton. One half of the carcass was retained and frozen for subsequent 
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mincing and carcass analysis of total fat and protein. 
After slaughter, loins from both sides of the carcass were cut into 40mm chops to yield 8 chops per 
animal. The chops were stored at 1°C and at 0,4, 8, 10, 12,22, 30,40 and 627 hours post-
c-slaughter, pH and tenderness were measured. Tenderness was assessed following standard 
procedures using a MIRINZ tenderometer (Quality Assurance for Tenderness MIRINZ technical 
report 872, ISSN 0465-4390). pH was measured with a Hanna HI9025C portable pH meter with an 
Orion Ross combination spear tip pH electrode (81-63). 
7.2.5 Statistical analysis 
Data was tabulated in Quattro Pro spreadsheets and analyzed by Minitab Statistical Software 
package. Data was analyzed using ANOV A and Students t Test. 
7.3 Results 
7.3.1 Calpain proteases and calpastatin 
" The separation and quantification of calpain I, caJpain II and calpastatin was successful. Table 7.1 
summarises the activities of the separated enzymes. 
Animal Immunised Control 
Calpain I Calpain II Calpastatin Calpain I Calpain II Calpastatin 
1 0.52 1.24 0.45 1.12 ---0.72 0.37 
2 0.86 1.00 0.14 1.07 0.52 0.37 
3 0.69 0.88 0.07 0.99 0.30 0.27 
4 0.57 0.60 0.10 0.72 0.40 0.21 
--" 
5 0.43 0.88 0.18 0.32 0.24 0.15 
6 0.55 2.42 0.30 1.26 1.12 0.07 
7 1.12 1.38 0.04 1.03 0.78 0.10 
8 1.42 0.86 0.20 0.51 0.50 0.09 
9 1.52 0.58 0.03 0.83 1.06 0.03 
10 0.91 1.18 0.12 1.46 0.94 0.09 
Average 0.86 (±0.4) 1.10 (±0.5) 0.16 (±0.13) 0.93 (±0.3) 0.65 (±0.3)" 0.17 (±0.12) 
Table 7.1 Summary of cal pain I, calpain II and calpastatin activities (Units/gm) from LD 
. muscle of immunised and control rams. Enzymes were extracted using DEAE sephacel and a 
linear NaCI gradient, assaying followed the standard procedure described earlier (p<0.05). 
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Calpain II appears to decrease in the GH immunised animals compared to control. Calpain I and 
calpastatin were unaffected by the treatment. 
7.3.2 Antibody assay 
GH specific antibodies were assayed for 2 weeks after the last peptide injection. Figure 7.2 shows 
the response of GH antibody to the peptide immunisation. 
Antlbodv nlre/tOOml plasma 
Animal group 
• Antlbodv 
Figure 7.2 Growlh hormone antibodies produced in response to immunisation wilh GH peptide 
in different treatment groups. 
As anticipated, immunisation stimulated the production of significantly (p<O.OOl) higher levels of 
antibodies in the treated group. Specifically, the values were 0.081 (±0.OO6) and 0.26 (±D.015) for 
thecontroLand immunised groups respectively. There did not appear to be any effect of sex on the 
antibody titre production. 
7.3.3 Growth rates 
The live weights of all the animals were measured at birth, and approximately at 4 week intervals 
thereafter. The growth trends are shown in Figure 7.3 
There was no significant effect of immunisation on growth rates during the experimental period. 
However, it did appear towards the end of the trial that the immunised animals were growing at a 
;lightly greater rate than their control counterparts. Males grew faster than the females (p<0.05, 
jata not shown). This graph has been calculated to remove the effect of sex. 
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Figure 7.3 The effect of immunisation on the growth mtes (live weights) of lambs over the 
experimental period. 
, 7.3.4 hGRF challenge 
Human GRF was infused into all animals at 22 weeks of age. Figure 7.4 shows the effect of this 
on plasma GH between the two animal treatments. 
Plasma GH (ng/ml) 
160,---------------------------, 
140 
120 
100 ..... 
80 .... - ........................ . 
60 I ... , 
40 
20 
-- ____ T ____ ~ 
OL-~--~~--~--L__L __ ~~~ 
·15 0 15 30 45 60 75 90 105 120 
nme relative to hGRF Injection (min) 
- Control -I- Immunlsed 
, Figure 7.4 Plasma growtb honnone response to hGRF. and llIe effect of immunisation willI GH 
peptide. 
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As was expected, infusion with hGRF induced an increase in circulating GH. Immunisation with 
GH peptide did not appear to effect this response as there was no significant difference between the 
two response curves. 
7.3.5 Carcass composition 
Body composition parameters were measured after death, these are summarised in Table 7.2. 
Control Immunised 
Body Gain (kg) 24.4 25.0 
Carcass Protein (%) 34.9 34.4 
Carcass Fat (%) 53.8 54.6 
Kidney Fat (gm) 197 239' 
GR (mm) 13.3 14.5 
Omental Fat (gm) 516 572 
Table 7.2 Comparison of various carcass and noncar~ass parameters (p<0.05). 
Immunisation against GH had no effect on total carcass composition. There were, however, 
significant elevations in kidney fat. GR and omental fat were also higher in the immunised animals 
but not to a significant degree. 
7.3.6 Meat characteristics 
The pH and tenderness (Kgf) of the LD muscle were measured at various times post-slaughter. 
Figures 7.5 and 7.6 illustrate the post-slaughter changes in pH and tenderness respectively. 
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Figure 7.5 The effect of immunisation on the pH proflle of LD muscle stored up to 40 hours 
post-slaughter at 4°C. 
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Figure 7.6 The effect of immunisation on tenderness of LD muscle stored up to 40 hours post-
slaughter at 4°C. 
Both Figures 7.5 and 7.6 comply with the expected trends in pH and tenderness post-slaughter. 
There was no effect of immunisation on the rate of change or final pH or tenderness values. 
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7.4 Conclusion and discussion 
The use of monoclonal antibodies to modify animal growth ~d production has been successful in 
some experiments (Holder et al., 1988; Aston et al., 199111986; Pell et al., 1989). This experiment 
investigated whether the polyclonal antibodies produced in response to GH active site would be 
similarly successful. There are important advantages of this system of growth manipulation over 
other biotechnologies such as direct infusion of hormones (GH, IGF-I or GRF) or genetic 
manipulation (selective breeding or transgenics). Firstly, once biologically active topographic 
regions of GH are found and produced as commercial peptides, relatively few immunisations (=3) 
will be required to produce a long lasting response. This is suitable from a price and labour 
perspective, and individual immunisations are practical. But possibly more importantly, the 
public's perception of this approach is that it offer natural potentiation of an endogenous hormone 
product. In contrast, introduction of artificial products, whether it be hormones or DNA, is often 
seen by consumers as potentially harmful, and consequently discouraged by authorities. 
A modification of growth rate is possibly the most telling sign of the success of this work. 
However, this trial failed to establish any effect of the peptide immunisation on live weight gain 
during the trial period. This differs from other published works where growth rate has been 
successfully modified. For example, in a study by Holder et ai .. (1985) Snell dwarf mice treated 
with a hGWmAb (EB1) complex over a 6 week period displayed a significantly (p<0.OO1) greater 
weight gain than mice receiving hGH alone. A similar report was made by Wallis et ai., (1987) 
who infused a bGWmAb complex into hypophysectomised rats. Both reports showed that the 
weight gain is dependent upon the mAb used. Weight gain is not an exclusive response to GH 
modifications. For example, immunisation against SRIF in lambs (Spencer et al., 1983) and IGF-I 
in guinea pigs (Kerr et al., 1990) have also produced weight gain. Importantly, the studies 
referring ~~. G!l modified growth rates were both performed in GH deficient models. and 
consequently the potential for growth modification by GWmAb is high. This differs from the 
current experiments on sheep with normal GH levels. It may be that polyclonal antibody induced 
GH potentiation in sheep with adequate feed and no GH deficiency show a less conspicuous 
response to GH than in trials where GH is depressed. 
To ascertain whether GH activity had been successfully potentiated. a hGRF challenge was carried 
out. Examination of the GH response to hGRF is often when the GH axis has been modified, 
Dubreuil el al., (1989/1990). If polyclonal antibodies with potentiating ability had been raised 
again.st the peptide, then either a heightened or prolonged GH response to hGRF may be expected. 
Unfortunately. neither was seen and the plasma GH response to hGRF was not significantly 
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different between the immunised and control animals. Incompatibility between hGRF and the 
ovine GH axis is a possible explanation. However other studies have reported hGRF's capacity to 
augment GH in nonhuman systems. For example, in pigs (pommier et al., 1990) and cattle (Moore 
et al., 1992). Accordingly it seems unlikely that use of hGRF in ovine GH stimulation should be 
capricious. However, this is not a conclusive test since the mechanism of polyclonal antibody 
enhancement may be via a prolonged receptor association (Holder et al., 1987), the "restriction 
hypothesis" (Aston et al., 1991), or the induction of conformational changes in the GH molecule 
resulting in elevated activity (Holder et at., 1991). 
Several other suggestions have been made to explain the observed results. It is concei vable that the 
trial was terminated too soon. 'At 27 weeks the growth rates were beginning to diverge (Figure 7.3) 
and prolonging the trial may have enable a statistically significant deviation to be seen. It is' also 
possible that the topographical region where the peptide was modeled (aa 122-164) is not 
biologically active. In a study performed by Lewis et al., (1975) the controlled digestion of hGH 
eliminated residues 138-147 and resulted in increased growth activity and weight gain. TIlis 
suggests that a significant portion of the peptide used in this work actually has a depressive effect 
on GH activity. However, more recent work by Aston et al.,(l991) refutes this and asserts that 
, 
extensive peptide synthesis has revealed two loop regions (sequences 35-53 and 134-154) which 
possess GH-like activity. The second of these regions (134-154) is contained within our peptide, 
and therefore advocates its potential for activity. Furthermore, the antibodies raised against the 
peptide may have been neutralised by a secondary factor. TIlis proposal could be appraised by 
examining whether plasma IGF-I concentrations were greater in the immunised animals. This 
would also substantiate whether the region of GH used was biologically activ{}-in the stimulation of 
IGF which is thought to mediate the effects of GH. Studies in hypophysectomised rats (Wallis et 
al., 1987), have shown an increase in IGF-I levels following bGHlmAb administration. However, 
the fact that kidney fat and calpain II levels were significantly changed by immunisation suggests 
that neutralisation' of mAb activity did not occur. 
With respect to muscle quality, it is not clear whether the GH axis has affected parameters such as 
pH and tenderness, although positive effects on protein deposition and depression of protein 
degradation have been previously described (Doherty 1992; Oddy et ai., 1987). Indeed, where a 
hGRF analogue was infused into pigs, pH was not affected although other parameters, such as 
protein and muscle weight, showed differences (pommier et al., 1990). TIlis observation has been 
affirmed in these experiments where no change in pH or tenderness were observed, despite a 
significant reduction in calpain II occurring after immunisation. TIlis decline was not reflected in 
any s~gnificant improvement in tenderness, which is not surprising since calpain I is considered to 
be more crucial in establishing tenderness. 
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7.5 Summary 
It would appear from this work that the immunisation of no~al sheep with a GH peptide (122-
164) does induce an immune response. However, the polyclonal antibodies generated in response 
to the peptide region do not have the predicted capacity to potentiate the actions of endogenous 
GH. The reasons for this failure are unclear although there is little evidence to indicate that the 
fault lies with the peptide or the immune response. Possibly the largest difference between this 
trial and others, is that the animals used in the trial were typical with respect to endogenous GH 
levels. As a result of the unrestricted growth in the early stage of life, any slight potentiation of 
growth may only be reflected over the long term. Modification of the calpain system by the 
immunisation technique is interesting but there was no effect on any meat quality parameter 
suggesting its usefulness is limited. Nevertheless, it does indicate that immunomodulation has the 
potential to manipulate the calpain system, and this may be investigated further. 
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Chapter 8 
General discussion and conclusions 
i thesis has described a variety of approaches used for the extraction of calpain proteolytic system 
,ponents. In the results presented here only those employing DEAE-sephacel have been reliable. As a 
It, a DEAE-sephacel protocol based upon methods reported elsewhere has been developed and 
loyed. Some reservation exists, however, when comparing absolute results «eg., units of enzyme per 
1) determined by this method, with results seen in other research papers. Specifically, this is because 
is of enzyme appear to be lower in these experiments than reported elsewhere. A number of 
anations exist for this. It is likely that there is considerable animal variation in enzyme activities and 
!asing sample size may be advantageous. Differences in post-mortem sampling times can have 
latic effects on enzyme yields. This conclusion is based upon chapter 5 results which established a 
i fOf,calpains to decline post-mortem. Finally dissimilarities in laboratory protocols may contribute to 
. 
rences in reported enzyme levels. Little attempt was therefore made to compare enzyme values 
:tly to other work. However, standardisation upon a single protocol means that results contained in 
thesis are comparable. Future experiments would benefit from modifying this protocol so that 
Jarisons may be made universally. 
I attempt to better understand regulation of enzyme levels in the cal pain system:- this thesis included a 
which attempted to modify the GH axis in lambs. Infusion of the active site of GH produced a 
:lonal immune response, but failed to generate a change in growth of the treated lambs. Similarly, 
fects on calpain or tenderness were observed. Some data from this trial (growth rate curves) suggest 
1 delayed effect may have occurred and that prolonging the trial could have demonstrated a treatment 
t. However, this remains unproven. It might be interesting to experiment with antibody mediated 
in potentiation with respect to the calpains. A technique whereby calpain activity in vivo could be 
tented or repressed would provide a useful experimental model, and may have commercial 
::ation. 
thesis has presented evidence to suggest that lambs differing in their response to glucose (glucose 
IOce rate), also differ in the levels of calpain I. II and calpastatin. Hormonal status may, therefore, 
some-regulatory capacity over the calpain system. It is possible also that the lower protein content 
ved in slow clearance animals is due to elevated calpain I and II. and reduced calpastatin levels. A 
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: animal role for the calpains has not yet been discovered, and it would be interesting to establish a 
tmique which could quantify the ,cal pains in vivo. TItis could then answer the question raised by this 
hence ie., whether the calpain system is involved in nutrient partitioning, and whether it is regulated 
the endocrine system. The differences in cal pain levels between the lines of sheep did not correlate 
h a difference in meat tenderness. Other researchers have performed experiments which give 
:umstantial evidence of a role for the calpains. While evidence certainly supports this association (eg., 
;bition of calpain leads to tough meat, myofibrillar breakdown occurs in the presence of calpain) it 
I be difficult to prove in vivo as the process of tenderisation is multifactorial. Nevertheless, research 
ld be directed towards screening different animal breeds and attempting to correlate enzyme levels 
1 meat quality. Additionally, selective breeding may be able to generate high and low enzyme level 
:p for experimentation, and development of an understanding of the genetic basis for enzyme variation 
.d prove useful for biotechnologies employing DNA manipulation. 
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Appendix 1 
Method 1 (Koohmaraie 1990b) 
Sgm muscle sample 
J, 
Trim off fat and connective tissue 
J, 
Homogenise in 3vols Extraction Buffer: 
(SOmM TRIS, lOmM EDTA, lOmM BMCE, pH 7.8) 
J, 
Centrifuge (IS000rpm, ISrnin) 
J, 
Filter through glass wool/cheese cloth 
J, 
Adjust pH to 7.S with 1M Acetic acid 
J, 
Reduce conductivity to equal Equilibration buffer: 
(SOmM TRIS, ImM EDTA, lOmM BMCE, pH 7.5) 
use ice cold distilledldeionised H20 
J, 
Centrifuge (32000rpm, 60rnin) 
J, 
Load onto DEAE-Sephacel column 
(1.6cm x 40cm) 
J, 
Elute with linear gradient 0-400mM NaCI in Equilibration buffer 
(95ml each) 
J, 
Collect 64 x 3ml fractions 
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Appendix 2 
Method 2 (Wheeler & Koohmaraie 1991a2 
5gm muscle sample 
J, 
Trim of fat and connective tissue 
J, 
Homogenise in lOvol Extraction buffer: 
(50mM Sodium Acetate, lOmM B-MCE, lOmM EDT A, 
0.2% Triton X-lOO, pH 5.8) 
J, 
Centrifuge (32000rpm, 60min) 
J, 
Filter through glass wool/cheese cloth 
J, 
Adjust pH to 7.5 with 1M NaOH 
J, 
Dialyse for 20 hours against Dialysis buffer: 
(20mM TRIS, 5mM EDTA, lOmM B-MCE, pH 7.5) 
J, 
Centrifuge (32000rpm, 60min) 
J, 
Filter through glass wool/cheese cloth 
J, 
Load onto DEAE-Sephacel 
(1.5cm x 20cm) 
previously washed with Equilibration buffer-:--
(40mM TRIS, 0.5mM EDTA, lOmM B-MCE, pH 7.45) 
J, 
Elute Calpastatin and Cal pain I with linear gradient 
from 25-200mM NaCI in Equilibration buffer (90ml each) 
J, 
Elute Calpain II with 400mM NaCI in 
Equilibration buffer (60ml) 
J, 
Collect 72 x 3.3ml fractions 
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Appendix 3 _ 
Method 3 (Thomson et al., 1992) 
5gm muscle sample 
J, 
Trim off fat and connective tissue 
J, 
Homogenise in 6vol Extraction buffer: 
(40mM TRIS, lOmM EDTA, 0.2% Triton X-loo, lOmM B-MCE, pH 7.5) 
J, 
Centrifuge 
J, 
Filter through glass wool/cheese cloth 
J, 
Load onto 6ml DEAE-Sephacel 
(1.0cm x lOcm) 
previously washed with Buffer A: 
(40mM TRIS, 0.5mM EDTA, lOmM'B-MCE, pH 7.5) 
J, 
Elute Calpastatin with 6vols of 6ml Buffer A + lOOmM NaCI J, , . 
Elute Calpain I with 6vols of 6ml Buffer A + 200mM NaCl 
J, 
Elute Calpain II with 6vols of 6ml Buffer A + 400mM NaCl 
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Appendix 4 . 
Method 4 (Golpalakrishna et ai., 1985) 
Igm muscle sample 
J, 
Trim off fat and connective tissue 
J, 
Homogenise in Svol Extraction buffer: 
(SOmM TRIS, ImM EDTA, lOmM I3-MCE, lSOnM Pepstatin A, pH 7.S) 
J, 
Centrifuge (ISOOOrpm, 6Omin) 
J, 
Add 1O~ ImM Leupeptin 
J, 
Add Iml Phenyl Sepharose washed with O.2SM NaCI in Buffer A: 
(20mM TRIS, O.lmM CaC12, lOmM 13-MCE, 20J.1M Leupeptin, pH 7.5) 
J, 
Shake mixture end over ·end for Smin 
J, 
Add O.3ml SM NaCI 
J, 
Shake mixture end over end for Smin 
J, 
Add O.2ml O.lM CaCl2 
J, 
Shake mixture end over end for lOmin 
J, 
Pour into Column 
(O.8cm x 4.0cm) 
J, 
Wash with 2ml Buffer A + O.2SM NaCI 
J, 
Wash with 2ml Buffer A 
J, 
Wash with 2ml Buffer A - Leupeptin 
J, 
Elute Calpain II with 4ml O.lM NaCI in Buffer B: 
(20mM TRIS, ImM EGTA, lOmM I3-MCE, pH 7.S) 
J, 
Elute Calpain I with 2ml Buffer B 
~ .. '. .': -- -- .--.. -. , .'-
I ....... 
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Appendix 5 _ 
Method 5 
19m muscle sample 
J, 
Trim off fat and connecti ve tissue 
J, 
Homogenise in 5vol Extraction buffer: 
(50mM TRIS, 1mM EDTA, lOmM B-MCE, pH 7.5) 
J, 
Centrifuge (15000rpm, 60min) 
J, 
Add Iml Phenyl Sepharose washed with O.25M NaCl in Buffer A: 
(20mM TRIS, O.1mM CaC12, lOmM B-MCE, pH 7.5) 
J, 
Shake mixture end over end for 5min 
J, 
Add O.3ml 5M NaCl 
J, 
Shake mixture end over end for 5min 
J, 
Add D.2ml O.1M CaC12 
J, 
Shake mixture end over end for lOrnin 
J, 
Pour into Column 
(O.8cm x 4.0cm) 
J, 
Wash with 2ml Buffer A + O.25M NaCI 
J, 
Wash with 2ml Buffer A 
J, 
Wash with 2ml Buffer A 
J, 
Elute Calpain II with 4ml O.1M NaCI in Buffer B: 
(20mM TRIS, ImM EGTA, lOmM B-MCE. pH 7.5) 
J, 
Elute Calpain I with 2ml Buffer B 
t .'~ -
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